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  Abstract 
ABSTRACT 
During eukaryotic DNA replication, the replisome machinery slows down when the 
template DNA is damaged by endogenous or exogenous elements. To minimize the risk 
of fork collapse, “DNA damage tolerance” (DDT) mechanisms facilitate progression of 
DNA replication through damaged templates. A classical DDT response involves the 
use of DNA polymerases specialized in “translesion synthesis”. An alternative DDT 
mechanism consists in the reinitiation of DNA synthesis downstream of the damaged 
DNA, leaving a short unreplicated gap to be repaired post-replicatively. This 
mechanism requires the repositioning of the replisome and a new priming event. In 
2013, mammalian PrimPol protein was identified as the enzyme that mediates fork 
restart after different types of DNA lesions, including thymine photodimers caused by 
UV light. PrimPol is a member of the archaeal-eukaryotic primase (AEP) superfamily 
and is included in a clade of AEP proteins that contain both primase and polymerase 
activities. Recent studies confirmed a similar role for PrimPol at natural obstacles or 
difficult-to-replicate sites. Despite these antecedents, the contribution of PrimPol to 
maintaining genomic stability and its possible protective function against UV-induced 
DNA damage remained to be investigated.  
In this thesis we have studied the functions of mouse PrimPol in vivo. In a first 
approach, we participated in a structure-function study designed to understand the 
functional importance of several conserved amino acids in the PrimPol family, 
including two variants presumably associated to pathology: Y89D and Y100H. This 
study led to the identification of two amino acids located within a conserved WFYY 
motif that are indispensable for PrimPol functionality. 
In the second part of the thesis, we have studied the physiological consequences of 
PrimPol ablation in mammals using a KO mouse model. PrimPol
-/-
 mice are viable but 
hypersensitive to UV-induced DNA damage. Without PrimPol, skin healing after UV 
irradiation is compromised due to inefficient cell proliferation in the epidermis, which is 
necessary to replace cells with damaged DNA. The absence of PrimPol also caused a 
higher incidence of UV-induced papillomas, gender-specific alopecia, obesity and the 
development of aggressive tumors. Our results underscore the importance of 
mammalian PrimPol for the maintenance of genomic stability and strongly suggest a 
tumor suppression function in vivo.  
  Presentación 
PRESENTACIÓN 
Durante la replicación del DNA eucariótico, la maquinaria replicativa se ralentiza  
cuando el DNA molde ha sido dañado por causas exógenas o endógenas. Para 
minimizar el riesgo de colapso en las horquillas de replicación, los mecanismos de 
tolerancia al daño en el DNA (DDT) facilitan el proceso de replicación a través de 
moldes dañados. Un mecanismo clásico de DDT implica el uso de DNA polimerasas 
especializadas en síntesis “translesiva”. Un mecanismo alternativo consiste en la 
reiniciación de la síntesis de DNA tras la lesión dejando un segmento de DNA sin 
replicar que será reparado post-replicativamente. Este mecanismo requiere el 
reposicionamiento del replisoma y un nuevo evento de “primado”. En 2013, la proteína 
PrimPol humana fue identificada como el enzima responsable del reinicio de las 
horquillas ante diferentes tipos de lesiones en el DNA, incluyendo fotodímeros de 
timina causados por la luz ultravioleta (UV). PrimPol pertenece a la superfamilia de 
primasas de archaea y eukarya (AEP) y se incluye en un clado de proteínas AEP que 
contienen actividades primasa y polimerasa. Estudios recientes han confirmado una 
función similar para PrimPol ante obstáculos naturales en el genoma o puntos difíciles 
de replicar. A pesar de estos antecedentes, la contribución de PrimPol al mantenimiento 
de la estabilidad genómica y su posible función protectora ante el daño inducido por UV 
todavía no habían sido investigadas. 
En esta tesis hemos estudiado las funciones de la proteína PrimPol in vivo. En primer 
lugar, hemos participado en un estudio de estructura-función diseñado para comprender 
la relevancia funcional de varios aminoácidos conservados en la familia PrimPol, 
inlcuyendo dos variantes presuntamente asociadas a patologías humanas: Y89D y 
Y100H. Este estudio condujo a la identificación de dos aminoácidos, localizados en el 
motivo conservado WFYY, que son indispensables para la funcionalidad de PrimPol. 
En la segunda parte de la tesis, hemos estudiado las consecuencias fisiológicas de la 
pérdida de PrimPol en mamíferos utilizando un modelo KO murino. Los ratones 
PrimPol
-/-
 son viables pero hipersensibles al daño inducido por UV. Sin PrimPol, el 
proceso de curación de la piel tras haber recibido una dosis alta de UV se ve 
comprometido debido a la ineficiente proliferación celular en la epidermis, que es 
necesaria para reemplazar las células dañadas. La ausencia de PrimPol también causó 
una incidencia mayor de papilomas, alopecia, obesidad y desarrollo de tumores 
agresivos. Nuestros resultados muestran la importancia de PrimPol en el mantenimiento 
de la estabilidad genómica y sugieren una función supresora de tumores in vivo. 
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ABBREVIATIONS 
(6,4)-pp (6-4)pyrimidine-pyrimidone 
8-oxo-G 8-hydroxyguanine, 8-oxoguanine 
BAT Brown adipose tissue 
BER Base excision repair 
BrdU 5-Bromo-2’-deoxyuridine 
CldU 5-Chloro-2’-deoxyuridine 
CPD Cyclobutane pyrimidine dimer 
DDR DNA damage response 
DDT DNA damage tolerance 
dNTP Deoxyribonucleotide triphosphate 
DSB Double strand break 
FACS Fluorescence activated cell sorting 
FR Fork rate 
HCC Hepatocellular carcinoma or hepatocarcinoma 
HF Hair follicle 
H&E Hematoxylin and Eosin 
HR Homologous recombination 
HU Hydroxyurea 
ICL Inter-strand crosslink 
IdU 5-Iodo-2’-deoxyuridine 
IF Immunofluorescence 
IFE Interfollicular epidermis 
IHC Immunohistochemistry 
MEF Mouse embryonic fibroblast 
MMR Mismatch repair 
mtSSB Mitochondrial single-strand binding protein 
NER Nucleotide excision repair 
NHEJ Non-homologous end-joining 
PFA Paraformaldehyde 
Pol Polymerase 
RPA Replication protein A 
RS Replicative stress 
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SCE Sister Chromatid Exchange 
TLS Translesion synthesis 
TPA 12-O-tetradecanoylphorbol 13-acetate 
TS Template switching 
UTR Untranslated region 
UV Ultraviolet 
WAT White adipose tissue 
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INTRODUCTION 
Preservation of genome integrity is essential for cell viability and tissue homeostasis. 
The process of DNA replication is frequently challenged by DNA lesions induced by 
endogenous or exogenous agents, or intrinsic replication-fork obstacles such as unusual 
DNA structures and collisions with the transcriptional machinery proteins or other 
protein-DNA complexes (reviewed in Berti and Vindigni, 2015). Replicative stress (RS) 
can be defined as any DNA replication disturbance that generates stretches of ssDNA 
that are rapidly covered by ssDNA-binding protein (RPA). Notably, persistent ssDNA is 
harmful as it may cause breakages in the genome (Lindahl et al., 1993). Recently, a 
more general definition of RS has been proposed: slowing or stalling of replication fork 
progression and/or DNA synthesis (Zeman and Cimprich, 2014). The source, the 
extension and duration of RS determine the type of cellular response (reviewed in 
Muñoz and Méndez, 2016).  
A first strategy to cope with RS is the use of specialized bypass mechanisms known as 
DNA damage tolerance (DDT) to continue with DNA replication across the blocking 
element, before repairing it. In addition, the DNA damage response (DDR) also 
facilitates recognition, bypass and repair of DNA lesions (reviewed in Sale, 2012). 
Remarkably, if repair were to occur at a stalled replication fork, it would increase the 
chance of generation of a double strand break (DSB) (reviewed in Jackson et al., 2009). 
Therefore, DDT mechanisms are crucial to prevent fork breakages and to promote 
replication across lesions. Notably, those lesions that remain in the damaged template 
can be repaired postreplicatively. Both DDT and DNA repair require the use of DNA 
polymerases and primases, as it will be described in the next sections.  
1. Eukaryotic DNA polymerases 
DNA polymerases are enzymes that synthesize DNA. Their essential role takes part in 
genome duplication. During eukaryotic DNA replication, as the helicase MCM2-7 
unwinds DNA, Polε duplicates DNA continuously on the leading strand, while the 
lagging strand is replicated discontinuously by Polα and Polδ. PCNA is the processivity 
factor of the replisome and has a role on tethering Polε and Polδ (Figure 1; Lujan et al., 
2016). 
  Introduction  
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Besides DNA polymerases essential role in genome duplication, they are also crucial for 
protecting the cell against the effects of DNA damage. Remarkably, none of the known 
DNA polymerases are able to start DNA synthesis de novo; rather, they extend DNA 
from pre-existing “primer” molecule (DNA or DNA). 
 
Figure 1.  Central elements of the eukaryotic DNA replication fork. The schematic depicts the 
asymmetric nature of DNA synthesis. MCM, the DNA helicase (dark grey hexamer) along with its 
cofactors CDC45 and GINS, separates the two strands in the parental double helix. The ‘leading strand’ is 
replicated continuously by Polε, whereas the ‘lagging strand’ is replicated discontinuously. Polα/Prim1 
synthesize short RNA primers (orange) that are inicially elongated by Polα (red) and then further 
elongated by Polδ (green). Small grey trimeric rings represent single-stranded DNA-binding protein RPA. 
Small yellow circles represent dNTPs (reproduced from Lujan et al., 2016). 
Based on sequence homology and structural similarities, eukaryotic DNA polymerases 
have been classically grouped in four families: A, B, X and Y (Ito and Braithwaite, 
1991; reviewed in Lujan et al., 2016). As of today, up to 16 DNA polymerases in higher 
eukaryotes perform distinct (and possibly redundant) functions (Table 1). All 
structurally polymerases share a common organization in three domains, called finger, 
palm and thumb that form a cavity. In the bottom of this cavity, the palm domain 
contains three acidic residues that coordinate the two divalent metallic ions required. 
The fingers are implicated in the union of the incoming nucleotide and the DNA 
template, whereas the thumb holds the emerging double helix of DNA. This “right 
hand” topology is conserved in all the phylogenetic families of DNA polymerases. In 
addition, Y-family polymerases can bypass specialized lesions in the DNA template 
because of an additional labile domain called little finger (Figure 2; Ollis et al. 1985; 
Steitz and Steitz, 1993; reviewed in Friedberg, 2005). 
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Family 
DNA 
polymerase 
Gene Enzymatic activities Proposed functions 
B Polα POLA1 - DNA replication, checkpoint activation and HR 
B Polε POLE 3’-5’ exonuclease DNA replication, NER, MMR,HR and SHM 
B Polδ POLD1 3’-5’ exonuclease 
DNA replication, NER, MMR, HR, SHM and 
TLS 
B Polζ REV3L - TLS, mutagenesis, SHM and V(D)J 
A Polγ POLG 
3’-5’ exonuclease 
5’exonuclease 
Mitochondrial DNA replication and repair 
A Polθ POLQ 
3’-5’ exonuclease 
dRP lyase 
NHEJ, ICL repair, TLS, SHM and regulation of 
replication timing 
A Polν POLN ATPase, helicase ICL repair, NHEJ and TLS 
Y Polη POLH - TLS and SHM 
Y Polι POLI dRP lyase TLS, BER and SHM 
Y Polκ POLK - TLS and NER 
Y Rev1 REV1 - TLS and TLS polymerase “scaffold” 
X Polβ POLB dRP lyase, AP lyase BER, meiotic recombination and TLS 
X Polλ POLL dRP lyase BER, NHEJ, V(D)J, meiosis and TLS 
X Polμ POLM TdT V(D)J, NHEJ and TLS 
X TDT DNTT - Ig diversification 
RT TERT TERT - Telomere maintenance 
Table 1. Mammalian DNA polymerases. Most eukaryotic DNA polymerase proteins are named with 
Greek letters and the genes are named with the corresponding roman letter. It should be noted that Table 1 
shows only the catalytic subunit gene. BER: Base excision repair; TLS: Translesion synthesis; NHEJ: 
Non-homologous end-joining; ICL: Interstrand crosslink; SHM: Somatic hypermutation; MMR: 
Mismatch repair; HR: Homologous recombination; dRP: 5’-deoxyribose phosphate.  
 
Figure 2.  Common structural elements in eukaryotic DNA polymerases. Schematic representation of 
the crystal structure of (A) a canonical high-fidelity DNA polymerase and (B) a specialized DNA 
polymerase from the Y-family. Arrows indicate the catalytic site. Note the obvious difference in 
accessibility to both active sites. In addition to the canonical ‘thumb’ (orange), ‘palm’ (blue) and ‘fingers’ 
(yellow) domains, some specialized polymerases also have an extra domain known as ‘little finger’ 
(purple; reproduced from Friedberg, 2005). 
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1.1. DNA polymerases directly involved in DNA replication 
1.1.1. Nuclear DNA replication 
Nuclear DNA is replicated accurately by the coordinated action of DNA polymerases α, 
δ and ε. The catalytic subunit of Polα is not highly processive and lacks 3’5’ 
exonuclease proofreading activity. Polα is associated with a primase (Prim1) forming 
the Polα/primase complex that synthesizes and elongates RNA primers to initiate DNA 
synthesis (once per origin in the leading strand and once each Okazaki fragment in the 
lagging strand). Polε and Polδ are in charge of elongating these fragments in the leading 
and lagging strand, respectively. The rate of base substitution of both polymerases is 
approximately 10
-5
, the lowest of all the characterized DNA polymerases, and 
misincorporated nucleotides usually removed by the 3’5’ exonuclease activity (Figure 
1; reviewed in Lujan et al., 2016). An alternative model for replication in yeast has been 
proposed, which Polδ replicates both strand, and a switch to Polε occurs only upon 
DNA damage in the leading strand template, linking DNA-damage detection to the 
essential role for polymerase ε and associated checkpoint proteins (Johnson et al., 
2015). However, this model has been contested (Burgers et al., 2016) and it is unclear 
whether it will withstand the test of time.  
Although not a conventional DNA polymerase, telomerase (TERT) adds telomere 
repeat sequences to the 3’ end of telomeres in order to maintain chromosomal integrity. 
In humans, telomerase is active in stem cells but is normally absent in somatic cells 
(reviewed in Schmidt and Cech, 2015). 
1.1.2. Mitochondrial DNA replication 
The mitochondrial genome is replicated by a unique high-fidelity DNA polymerase, 
Polγ, which is encoded by the nuclear DNA (Wernette et al., 1988; Hansen et al., 2006). 
mtDNA is circular and composed by two strands referred as “heavy” and “light” chain, 
each one with its own origin of replication. The mechanism of initiation of mtDNA 
replication is poorly understood as there are three proposed replication models. In the 
asymmetric “strand displacement” model, one strand begins to replicate first, displacing 
the other strand. The second strand begins replicating in the opposite direction at the 
point when replication is completed on the first strand (Brown et al., 2005). In a second 
model, mtDNA replicates symmetrically, with leading- and lagging-strand synthesis 
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progressing from bidirectional replication forks initiated at multiple points within large 
versions (Bowmaker et al., 2003). The third model, RNA incorporation during mtDNA 
replication (RITOLS), which is a modification of the asynchronous model of replication 
(first model), argues that large regions of single stranded DNA do not exist, rather, the 
lagging-strand template is largely protected by RNA and subsequently converted into 
DNA (Yasukawa et al., 2006). None of the models are totally accepted and therefore 
they are under debate, although in all the proposed models Polγ is suggested to be the 
mitochondrial replicative DNA polymerase. However, the protein implicated in the 
initiation or priming of the mtDNA replication is still unknown. Recently it was 
discovered that mitochondrial RNA polymerase (POLRMT) can initiate replication of 
mtDNA synthesizing primers from the light-strand origin of DNA replication on leading 
stran (Fuste et al., 2010). However, the role of POLRMT only fits in the symmetrical 
replication model but does not explain primers synthesis on the lagging strand that is 
suggested as a major mechanism in the RITOLS model. This implies that there might be 
distinc mode of DNA priming and additional primases involved in the replication of the 
mtDNA. 
1.2. DNA polymerases in DNA damage tolerance 
There are two main DDT mechanisms that involve the use of DNA polymerases, and 
both are highly conserved throughout the eukaryotic kingdom. One involves the 
invasion of a homologous template strand, usually a sister chromatid, and is generally 
“error-free”. The other involves the use of specialized DNA polymerases whose active 
site allows the insertion of nucleotides opposite the damaged template (reviewed in 
Branzei, 2011). Biochemically, translesion synthesis (TLS)-polymerases display low 
fidelity and for this reason, TLS is considered error-prone (Walker et al., 2009). 
However, in some cases, TLS DNA polymerases are able to insert preferentially the 
correct nucleotide opposite to the lesion. The choice between the two modes of DDT is 
generally dictated by specific posttranslational modifications in PCNA (Figure 3; Hoege 
et al., 2002). Notably, in eukaryotes, when ongoing forks stall, dormant origins may be 
activated to ensure completion of replication. Nevertheless, if two convergent forks 
stall, in regions lacking of back-up origins, cells must restart at least one of these forks 
to duplicate all the genome (Ge et al., 2007; Ibarra et al., 2008). 
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Figure 3. DNA damage tolerance (DDT) mechanisms. When replication forks encounter DNA lesions, 
the DNA polymerase stalls but the helicase continues to unwind the parental DNA, generating stretches 
of ssDNA that are rapidly covered by RPA. Before the lesion is repaired, two main alternatives exist to 
promote DNA replication through the lesion: mutagenic TLS, favoured by PCNA-Ub (top branch) or 
error-free TS, favoured by PCNA-(Ub)n (bottom branch). The names of the proteins playing key roles in 
these pathways are indicated. 
1.2.1. Template switching (TS) 
When PCNA is polyubiquitinated by Rad18, Rad5, and Ubc13-Mms2 and sumoylated 
by Ubc9 and Siz1 this mode of DDT is preferred (Hoege et al., 2002; Branzei et al., 
2008). In TS, lesions are bypassed by temporally replacing the damaged template with 
the intact template provided by the newly synthesized daughter strand of the sister 
chromatid (reviewed in Chand and Cimprich, 2009). The X-shaped structures formed 
after the stand invasion can be processed by the resolvosome without generating 
crossovers (Raynard et al., 2006). However, new evidence in yeast suggests that in 
some cases TS may also produce complex chromosomal rearrengements (reviewed in 
Heyer et al., 2010; Branzei et al., 2011). Interestingly, Polα/Prim1 complex promotes 
TS in yeast, suggesting that a priming event could be needed during TS (Fumasoni et 
al., 2015).  
1.2.2. Translesion synthesis (TLS) 
PCNA monoubiquitylation at Lys164 by Rad6 and Rad18 favors TLS over TS (Hoege 
et al., 2002). To date, the list of known TLS polymerases includes all members of the 
Y-family (Polη, Polι, Polκ and Rev1), members of the B-family polymerases (Pol ζ and 
Polδ), the A-family (Polθ and Polν) and the X-family (Polβ, Polμ and Polλ) (reviewed 
  Introduction  
17 
 
in Knobel and Marti, 2011). Each polymerase has evolved to bypass specific lesions and 
can perform a set of distinct functions during DDT. The precise physiological role for 
each TLS polymerases has not been established but they can deal with lesion that 
include UV photoproducts, 8-oxo-G, deoxyuracil, bulky adducts, abasic sites, intra and 
inter strand-crosslinks, benzo(α)pyrene-guanine and thymine glycol (reviewed in Loeb 
and Monnat 2008).   
The current model for the TLS mechanism implicates two steps. First, the replicative 
polymerase is substituted by a TLS-polymerase that incorporates nucleotide/s opposite 
the lesion. Then, the same or a different TLS polymerase elongates the newly 
synthesized strand with several nucleotides to allow the replicative polymerase to be 
engaged again (Shachar et al., 2009). Polη, Polι and Polκ are polymerases that can 
perform the insertions, directly opposite of the lesion, while the extension mainly relies 
on Pol ζ and in some cases Polκ (Livneh et al., 2010). Other polymerases can act as 
“inserter” or “extender” depending on the lesion. For instance, Polθ can insert adenine 
opposite an AP site, but it can also carry out the extension step from mismatches after 
error-prone dNTP incorporation by Polι (Seki et al., 2004; 2008). In specific cases, the 
insertion and the extension is performed by the same TLS polymerase such as Polν 
opposite to thymine glycol or Polλ against AP sites (reviewed in Knobel and Marti, 
2011). 
It should be noted that TLS can occur at stalled forks or post-replicatively. In the latter 
case, replication must be re-initiated downstream of the damaged DNA. Rev1 has the 
particularity to bind to PCNA and Polη, Polι, Polκ, Polδ or Pol ζ. Hence, Rev1 could 
provide an “exchange platform” for TLS polymerases at stalled forks to reinitiate the 
DNA synthesis (Murakumo et al., 2001; Ohashi et al., 2004; Guo et al., 2003; Guo et 
al., 2006; Acharya et al., 2009; Yoon et al., 2015). Interestingly, Rev1-PCNA 
interaction is independent of PCNA ubiquitylation and suggests a new model for the 
regulation of TLS polymerases: their recruitment to stalled forks during S-phase could 
be mediated by Rev1, while Ub-PCNA would be a signal to recruit them during 
postreplicative gap filling (Edmunds et al., 2008; reviewed in Sale, 2012). 
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1.3. DNA polymerases in DNA repair 
There are several DNA repair pathways in the nucleus; the choice of the appropriate 
pathway depends on the type of DNA damage. Thereby, the DNA substrates generated 
in each type of damage are different. Almost every DNA polymerase participates in 
DNA repair; some are specialized in one pathway; others can used by multiple DDR 
pathways (Figure 4; reviewed in Lange et al., 2011). The main mechanisms of repair 
and the polymerases involved in each one of them are described briefly in this section. 
 
Figure 4. A panoply of DNA polymerases participates in DNA repair to maintain genomic stability. 
DNA is continually exposed to damaging agents, both exogenous and endogenous. The choice of repair 
mechanism is largely defined by the type of lesion and the phase of the cell cycle. The DNA polymerases 
involved in each repair mechanism are shown. AP: apurinic/apyrimidinic site; 8-oxo-G: 8-oxo-2’-
deoxyguanosine; CPD: cyclobutane pyrimidine dimer; (6,4)-pp: 6-4 photoproduct; ICL: Inter-strand 
crosslink; DSB: Double-strand break; BER/NER: Base/Nucleotide Excision Repair; HR: Homologous 
Recombination; NHEJ: Non-Homologous End-Joining; MMR: Mismatch Repair. 
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1.3.1.  Nucleotide Excision Repair (NER) 
This process comprises global genome repair (GG-NER) and transcription-coupled 
repair (TC-NER). This pathway removes a variety of bulky, DNA-distorting lesions, 
including UV-induced damage and chemical adducts. This process comprises global 
genome repair and transcription-coupled repair. The initial recognition of damaged 
DNA by the NER proteins is followed by dual incision to excise a short oligomer (30nt) 
including the lesion; the subsequent gap is filled and ligated by Polδ, Polε and/or Polκ 
(reviewed in Gillet and Scharer, 2006; Hanawalt and Spivak, 2008; Ogi et al., 2010). 
1.3.2. Base Excision Repair (BER) 
This repair process removes damaged bases such as oxidation (8-oxo-G), alkylation or 
abasic sites. BER has been classified according to the length of the repair patch as either 
“short-patch BER” (one nucleotide) or “long-patch BER” (more than one nucleotide). 
First, a DNA glycosylase recognizes the damage and eliminates it leaving an abasic site 
(AP: apurinic/apirimidinic site). Then an AP endonuclease cleaves the AP site to yield a 
3’OH group adjacent to a 5’deoxyribosephosphate (dRP). Combined the action of a 
DNA glycosylase and an AP lyase may leave a one nucleotide gap between the 3’OH 
and the 5’ phosphate. In higher eukaryotes, Polβ is the main polymerase that fills the 
short-patch BER (reviewed in Almeida and Sobol, 2007), but in its absence, the reaction 
can be carried out by Polλ or Polθ (Braithwate et al., 2005; Prasad et al., 2009). These 
polymerases typically insert a single dNTP and remove the 5’dRP left through its dRP 
lyase activity. In long-patch BER (2-10 new dNTPs), DNA synthesis is probably 
performed by Polδ and Polε along with processivity factor PCNA. These two 
polymerases perform strand displacement meaning that the downstream 5’DNA end is 
“displaced” to form a flap (Stuki et al., 1998). Polβ has been also described to perform 
long-patch displacing synthesis, so it can participate in both BER pathways (reviewed in 
Almeida and Sobol, 2007). The low fidelity Polι binds to XRCC1 (an important BER 
factor) and is the only Y-family polymerase with dRP-lyase activity (Petta et al., 2008; 
Bebenek et al., 2001). Other DNA polymerases like Polλ and Polθ have been proposed 
as backup enzyme for BER (Braithwaite et al., 2005; Prasad et al., 2009). 
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1.3.3. Mismatch-repair (MMR) 
This pathway recognizes the mismatch, additions or deletions generated by replicate 
DNA polymerases. Their repair implies the excision of a region in the newly 
synthesized strand that contents the error, followed by a correct DNA synthesis 
(reviewed in Hanawalt and Spivak, 2008). Polε and Polδ have been implicated in the 
excision through their exonuclease activities (Longley et al., 1997; reviewed in Kunkel 
and Erie, 2015). 
1.3.4. DSB repair 
DSB are particularly dangerous as they are a leading cause of chromosomal 
rearrangements (Jackson et al., 2009). DSB may occur during physiological process 
such as DNA replication, meiosis or V(D)J recombination, or as a consequence of 
external DNA damaging agents such as UV-light or ionizing radiation. These lesions 
can be repaired through two different pathways: Homologous recombination (HR) and 
non-homologous end-joining (NHEJ).  
1.3.4.1. Homologous Recombination (HR)  
This repair pathway is used after S-phase when a homologous DNA molecule is 
available and requires the processing of the DSB 5’ end by an exonuclease 5’-3’ which 
generates 3’ overhangs that are covered by RPA. The union allows the recruitment of 
Rad51 forming a nucleoproteic filament. Rad51 directs the single strand invasion to the 
sister chromatid, followed by faithful DNA synthesis using the replicative polymerases 
(Bärtsch et al., 2000; reviewed in Renkawitz et al., 2014). In postsynapsis three 
subpathways of HR are distinguished (BIR, SDSA and dHJ), each with specific 
enzymatic requirements that have been only partially defined (reviewed in Heyer et al., 
2010). Polβ is also required in the repair of the DSB through HR during early meiotic 
processes (Kidane et al., 2010). Notably, this mechanism is also used to repair ICL and 
ssDNA gaps (reviewed in Heyer et al., 2010).  
1.3.4.2. Non-Homologous End-Joining (NHEJ) 
NHEJ is used to repair DSB when the sister chromatid is not available. The first step 
consists of DSB recognition by the heterodimer Ku70/Ku80 that covers DNA and 
prevents the degradation of either end. Then, DNA-PK favors the linkage of both sides 
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through protein-protein interaction. In most cases, the ends are processed, leaving small 
gaps that must be filled. Polλ and Polν participate in this process. Both polymerases 
interact with the NHEJ machinery through its BRCT domain. Apart from Polλ and Polν, 
Terminal deoxynucleotydil Transferase (TdT) has been implicated in the natural NHEJ 
that occur in immunoglobulin V(D)J gene recombination in B-cells. Polθ participates in 
the class switch recombination in B-cells (Yousefzadeh et al., 2014) and also in an 
alternative NHEJ (alt-NHEJ) which is independent of Ku70/Ku80 (reviewed by Wood 
and Doublié, 2016).  
1.3.5. Inter-strand crosslink (ICL) repair 
ICL lesions can be caused by nitrous gas, psoralen, aldehydes, cisplatin and ionizing 
radiation. These lesions are highly cytotoxic and their repair mechanism is under active 
investigation. Polθ and Polν, both belonging to the A-family, are known to participate in 
ICL repair. Both possess a helicase linked to polymerase domain and have high 
processivity (Seki et al., 2003; Marini et al., 2003). ICL repair implies the use of TLS 
polymerases (Rev1, Polν and Polζ) to allow the replication progress in HR events 
(reviewed in Deans and West, 2011). 
1.3.6. DNA repair in the mitochondria 
Mitochondria also possess effective DNA repair mechanisms which remains less 
understood. Both BER (short-patch and long-patch) mechanisms are important for the 
repair of mtDNA, as mitochondria suffer from ROS generated during oxidative 
phosphorylation (Akbari et al., 2008). MMR has also been described to occur (de 
Souza-Pinto et al., 2009). Polγ is the only polymerase described in these two pathways 
(Copeland et al., 2010). It is still not known if other mechanisms are involved in the 
repair of other specific lesions in mtDNA, such as bulky adducts or UV-photoproducts. 
For instance, it was found that UV photoproducts are persistent in the mitochondrial 
genomes. In addition to Polγ, Polζ and the newly discovered PrimPol have been found 
in the mitochondria and the lack of any of them perturbs mtDNA replication (García-
Gómez et al., 2013; Singh et al., 2015). 
2. DDR against UV-induced DNA damage 
UV-irradiation is known to induce deleterious effects on nucleic acids and proteins, 
which have been linked to malignant melanoma and other skin cancer types (Narayanan 
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et al., 2010; Rastogi et al., 2010). The UV spectrum of sunlight is divided into three 
regions: UVA (320-400nm), UVB (290-320nm) and UVC (320-400nm). While UV-C 
light is almost completely absorbed by the stratospheric ozone layer, UVA and UVB 
reach the earth’s surface. UVB is considered to be more carcinogenic than UVA, as it 
directly causes two types of DNA lesions that compromise the conformation of the 
DNA helix: cyclobutane pyrimidine dimers (CPD) formed between adjacent thymidine 
(T) or cytosine (C) residues, and 6-pyrimidine-4-pyrimidone photoproducts ((6,4)-pp). 
The most abundant photoproduct is the CPD, which constitutes 80% of the total lesions. 
Despite the fact that (6,4)-pp is less abundant  (20% of the lesions), this adduct is of 
high biological importance and known to be much more mutagenic than CPDs. Besides 
this in mice, CPDs and (6,4)-pp lesions are repaired with different kinetics in the 
epidermis and dermis (Qin et al., 1995). Most (6,4)-pps are removed from the skin 
within 3 days. In contrast, the removal of CPDs is gradual. More than 80% if CPDs are 
removed from epidermal cells within 5 days, but less than 50% are removed from 
dermal fibroblasts in the same time frame. These characteristics are consistent with the 
repair of UV-lesions observed in mouse and human cultured epidermal keratinocytes 
and dermal fibroblasts (Courdavault et al., 2005; Mitchell et al., 1990).  In addition, 
UVA and UVB damage DNA indirectly by the generation of reactive oxygen species 
(ROS), which in contact with DNA lead to the formation of 8-oxo-G and deoxyuracil 
lesions. These lesions do not distort the DNA helix and they are therefore less harmful 
than the photodimers (reviewed in Lommel and Hanawalt, 1993; Zaidi et al., 2012).  
As described before, these lesions can be bypassed during DNA replication to be 
repaired postreplicately. In vitro, CPD lesions can be bypassed by Polη, Polι, Polκ, 
Polμ, Polθ and Polζ; (6,4)-pp can be bypassed by Polη, Polι, Polθ and Polζ and 8-oxo-G 
by Polι, Polκ, Polμ, Polβ, Polλ and Polη (reviewed in Knobel and Marti, 2011). In 
human cells and mouse fibroblasts it has been shown that in opposite to UV lesions 
Rev1 is indispensable for TLS mediated by Polη, Polι and Polκ but is not required for 
TLS by Polζ. Therefore the current model for TLS synthesis against CPDs and (6,4)-pps 
is thought to occur either by Rev1 (Polη, Polι and Polκ) or Polζ  (Yoon et al., 2015). 
This insertion performed by TLS polymerases is normally mutagenic, although it is 
worth saying that Polη catalyzes error-free synthesis opposite to CPD lesions (Johnson 
et al., 2000). Indeed, mice deficient in Polη or/and Polι are sensitive to UV-induced 
tumorigenesis (Lin et al., 2006; Ohkumo et al., 2006) and mice deficient in Polζ present 
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an extreme sensitive to UV irradiation developing skin ulcers with low dose of UV-B 
(Lange et al., 2013). Moreover, Xeroderma Pigmentosum variant syndrome (XP-V) is a 
human disorder where severe truncations of the protein Polη results in a strong 
susceptibility to sunlight-induced skin cancers (Kannouche and Stary, 2003).  
Cells have evolved with specific mechanisms to repair these lesions. CPD lesions can 
be removed by GG-NER or TC-NER mechanisms. In transcriptionally active genes, 
CPD clearance is faster due to the TC-NER mechanism. In contrast, (6,4)-pp are 
preferentially removed by GG-NER (Vreeswijk et al., 1994; Balajee et al., 1999). Mice 
deficient in XPC (GG-NER) or Ercc6 (TC-NER) displayed extreme UV susceptibility 
(Berg et al., 2000; Doig et al., 2006). As explained before, 8-oxo-G lesions are also 
produced after UV irradiation. This type of lesion is rapidly repaired by BER pathway. 
Again, mice deficient in proteins involved in this pathway such as Ogg1 developed SCC 
and mesenchymal tumors after chronic exposure to UV-radiation (Kunisada et al., 
2005).  
3. DNA primases 
The function of DNA primases is to initiate DNA replication by synthesizing short 
RNA oligonucleotides de novo, which then serve as primers for replicative polymerases. 
Due to the semi-discontinuous nature of DNA replication, primases are essential not 
only at the replication origins, but also during the synthesis of the lagging strand where 
they initiate the synthesis of each Okazaki fragments (Ogawa et al., 1985; van der Ende 
et al., 1985; reviewed in Frick and Richardson, 2001). Unlike in the nucleus, no 
primases have been described to operate in mtDNA. Instead, primer synthesis relies on 
mitochondrial RNA polymeras (Wanrooij et al., 2008; Fuste et al., 2010).  
In eukarya, the canonical primase is comprised of two subunits (Prim1/Prim2), and it 
forms a complex with Polymerase α, itself a heteromider formed by PolA1-PolA2 
(Foiani et al., 1991; reviewed in Frick and Richardson, 2001; Muzi-Falconi et al., 
2003). Prim1 is the catalytic subunit and belongs to the large superfamily of Archeo-
Eukaryotics primase (AEP), compared with other DNA and RNA polymerases, exhibits 
the lowest fidelity. Nonetheless, replication accuracy is not compromised since the 
RNA primers are eliminated by nucleases during Okazaki fragment maturation and 
replaced with DNA, synthesized by the replicative polymerases (Sheaff and Kuchta, 
1994). The Polα-Primase complex can interact with a broad network of proteins, 
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including Cdc45, RPA and PARP (Weisshart et al., 2000). The recruitment of Polα-
primase complex onto replication is believed to occur through the interaction with 
Cdc45-MCM2-7 (Kukimoto et al., 1999; Labib et al., 2002). The role of the interactions 
with PARP is still not clear, although it may be involved in recruiting the primase to 
damaged sites (Dantzer et al., 1998). In Xenopus laevis the activation of the checkpoint 
requires the recruitment of the Polα-Prim-Cdc45 onto chromatin (Michael et al., 2000).  
The AEP superfamily includes primases in archaea, virus and eukaryotes, whereas all 
the bacterial primases belong to the DnaG-like superfamily (Kuchta and Stengel, 2010). 
AEP superfamily comprises 13 major families, 12 of which can be also organized into 
three higher-order clades; the AEP-proper clade, the nucleocytoplasmic large DNA 
viruses (NCLDV)-herpesvirus clade and the PrimPol clade (Iyer et al., 2005; reviewed 
in Guilliam et al., 2015). 
Most AEP members are heterodimeric, containing a small catalytic subunit and a large 
accessory subunit. The AEP superfamily is distinguished by a characteristic catalytic 
core composed by three conserved motifs (A, B and C). Motif A or hhhDhD/E motif 
(where h is an hydrophobic residue), motif B or sxH motif (where s is a small residue) 
and motif C or an hD/E motif (Figure 5; Iyer et al., 2005). Motif A and C are involved 
in divalent metal ion coordination for catalysis, whereas motif B is required in 
nucleotide binding (Augustin et al., 2001; Lao-Sirieix et al., 2005; Lipps et al., 2004). 
This mechanism is supported by structural information extracted from the preternary 
complex of a mycobacterial AEP bound to dsDNA and the incoming nucleotide (UTP; 
Brissett et al., 2011). Mutagenesis studies have shown that these three motifs are crucial 
to maintain the catalytic activity (Figure 5; Copeland et al., 1995; Augustin et al., 2001; 
Lipps et al., 2003; Della et al., 2004; Galal et al., 2012). In addition, some AEPs also 
possess a Zn binding motifs and helicase domains (Iyer et al., 2005).  
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Besides their fundamental role in DNA replication, AEP proteins have been also 
identified in DSB repair through NHEJ in prokaryotes (reviewed in Guilliam et al., 
2015). In addition, a member of the AEP superfamily, PrimPol, has been recently 
involved in a new DDT mechanism (Mourón et al., 2013). 
4. PrimPol a novel primase and polymerase enzyme in eukaryotes 
Human PrimPol gene (CCDC111), located in chromosome 4q35.1, was predicted to be 
a member of the AEP family, specifically to the PrimPol clade (Iyer et al., 2005). 
PrimPol contains the active-site A, B and C motifs and a putative Zn ribbon similar to 
that of herpesvirus UL52 primase and other AEP-like enzymes. Evolutionary, PrimPol 
an archaic enzyme present in the majority eukaryotic species, with the notable exception 
of fungi (Figure 6; García-Gómez et al., 2013; Bianchi et al., 2013; Wan et al., 2013).  
Members of the PrimPol family have the motif A variant DxE instead of the DxD motif 
present in most other AEP members. These are two of the three amino acids (D114, 
E116 and D280) in charge of metal coordination at the active site (Figure 6; García-
Gómez et al., 2013; Bia nchi et al., 2013; Wan et al., 2013).  
Figure 5. A common fold structure for the 
PrimPol proteins from the AEP family. Modeling 
of the pRN1 ORF904 protein, the first AEP primase 
defined in the Prim-Pol clade. The solvent-accessible 
surface is colored. Yellow and orange colors 
correspond to invariant and conserved residues in the 
AEP family, respectively. Essential residues for DNA 
polymerase/primase activity are indicated (taken from 
Lipps et al., 2004). 
A 
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Figure 6. Conserved motifs in human PrimPol protein. A. Main conserved regions of representative 
proteins from different clades in the AEP family. Large dots indicate metal ligands (in red), nucleotide 
ligands (purple), and demonstrated (cyan) or potential (light blue) cysteine residues forming a Zn finger. 
Small dots indicate invariance within each group of AEP-related enzymes. Sequence alignment provided 
by Dr. Luis Blanco (García-Gómez et al., 2013). B. Primary structure of human PrimPol indicating the 
positions of the conserved A, B and C motifs in the AEP domain, a Zn finger domain and an RPA-
binding domain. (RBD). 
In vitro, PrimPol possesses both primase and polymerase activity; which it is able to 
synthesize short oligonucleotides de novo, and it can also elongate prexisting primers. 
Strikingly, PrimPol primase activity can use either dNTPs and NTPs or a combination 
of both. PrimPol can elongate primers, again, using either dNTPs or NTPs, albeit with a 
much higher efficiency with dNTPs. The nature of the pre-existing primer (DNA or 
RNA) does not affect the polymerase activity of PrimPol. When D114 and E116 (DxE) 
were converted into alanines (AxA mutant) by site-directed mutagenesis, both primase 
and polymerase activities were abolished. Hence, primase and polymerase activities 
share a common site (García-Gómez et al., 2013; Bianchi et al., 2013; Wan et al., 
2013). 
PrimPol is a low-processivity, error-prone polymerase and it lacks proofreading 
activity. The base substitution rate of PrimPol (51x10
-5
) is in the range of the X-
polymerases family and the single nucleotide insertion/deletion (indel) rate (310x10
-5
) is 
as high as the Y-polymerases family (Martínez-Jiménez et al., 2015). Interestingly, 
PrimPol can perform TLS-synthesis in vitro in front of a several type of DNA lesions 
including common oxidative DNA lesions (8-oxo-G and deoxyuracil) and UV-induced 
CPDs (García-Gómez et al., 2013; Bianchi et al., 2013; Mourón et al., 2013; Zafar et 
al., 2014). What is more, it can bypass one of the most complex lesions, (6,4)-pp and 
apurinic sites (AP). In these cases, PrimPol is capable of realigning the primer end to a 
B 
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downstream position, looping out the lesion without copying it (García-Gómez et al., 
2013; Mourón et al., 2013).  
4.1. Repriming downstream of a DNA lesion 
In the DDT response, lesions can be bypassed by the initiation of a new DNA strand 
downstream of the damaged template, leaving behind an unreplicated ssDNA gap to be 
repaired post-replicatevely. This mechanism was originally, reported in bacteria, yeasts 
and mammalian cells particularly after UV irradiation (Heller and Marians, 2006; Lopes 
et al., 2006; Langston and O’donnell, 2006; Callegari and Kelly, 2006; Callegari et al., 
2010; Elyers et al., 2011). Reinitiation of DNA synthesis ahead of the lesion strictly 
requires a primase activity. Whereas in the lagging strand this repriming event could be 
readily performed by Polα/Prim1 complex, it is not clear which enzyme acts in the 
leading strand. Recent work in murine and human cells has proposed that PrimPol 
catalyzes these priming events to facilitate fork progression after UV challenge or dNTP 
attrition (Figure 7; Mourón et al., 2013).  
 
 
Figure 7. A repriming event downstream of the DNA lesion facilitates DDT. In a situation of 
replication stress such as the one described in Figure 3, a repriming event may occur, facilitating the 
restart of DNA synthesis downstream of the lesion. The short unreplicated gap can then be fixed post-
replicatively by either TLS, HR or other DNA repair pathways. 
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4.2. PrimPol subcellular distribution suggests nuclear and mitochondrial functions 
A biochemical fractionation of cells revealed that PrimPol is distributed in the cytosol, 
mitochondria and nucleus. It has been postulated that it may be involved in DDT in both 
cellular compartments with DNA. Indeed, PrimPol gene silencing or ablation affects 
mitochondrial and nuclear DNA replication (García-Gómez et al., 2013; Mourón et al., 
2013). 
PrimPol associates with nuclear chromatin during G1 and S phase, and influences the 
rate of fork progression, even in the absence of exogenous challenges. PrimPol 
deficiency induces RS in otherwise unchallenged conditions. Therefore, PrimPol is 
proposed to have a role during normal DNA replication, probably monitoring fork 
progression through slow replication zones or other natural impediments. Indeed, 
PrimPol is required to restart forks stalled by HU, which reduces dNTP levels. 
Additionally, PrimPol is recruited onto chromatin after UV irradiation, independently of 
the checkpoint response (Figure 8). It has been reported that PrimPol C-terminal domain 
interacts with RPA1 (RPA70; Figure 6B; Wan et al., 2013; Guilliam et al., 2014). 
Therefore the RPA binding domain (RBD) of PrimPol, together with the Zn finger 
domain, may act as a chromatin-recruitment mechanism. Interestingly, PrimPol also 
interacts with mitochondirla single strand binding protein (mtSSB) suggesting the same 
mode of recruitment to mtDNA.  
  
The primase activity of PrimPol is required to bypass UV-induced lesions in vivo, as 
primase-null PrimPol versions with intact TLS polymerase activity failed to promote 
fork restart (Figure 9; Mourón et al., 2013). PrimPol and Polη, both known to efficiently 
Figure 8.  PrimPol is recruited onto DNA 
damaged by UV irradiation in HeLa cells. In 
cells treated with a UV-laser as described 
(Mouron et al., 2013), GFP-tagged PrimPol can 
be seen rapidly recruited onto the UV-damaged 
site. PCNA and 53BP1 are also shown as positive 
controls. 
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bypass CPD lesions in vitro, act independently to promote fork progression through 
UV-induced damage suggesting that PrimPol would initially reprime ahead of the DNA 
lesion leaving an unreplicated gap to be repaired post-replicatively by Polη (or other 
TLS polymerases) or HR (Mouron et al., 2013). Recent studies also support that 
PrimPol acts preferentially through its primase activity for replicative tolerance of G 
quadruplexes in DT40 cells (Schiavone et al., 2016). In avian cells, PrimPol has shown 
to reprime DNA synthesis also after chain-terminating nucleosides (CTNAs), such as 
azidothymidine or cytarabine (important antivirals) (Kobayashi et al., 2016).  
Whether PrimPol’s TLS activity is important for other specific lesions remains to be 
elucidated. The lack of PrimPol also prevents the recovery of mtDNA copy number 
after transient drug-induced mtDNA depletion. The fact that PrimPol efficiently 
bypasses 8-oxo-G lesions suggests that PrimPol could act as TLS in the mitochondria 
(García-Gómez et al., 2013). PrimPol interacts with Twinkle, the mitochondrial 
helicase, and in vitro data has shown that Twinkle enhances PrimPol DNA synthesis on 
both undamaged and damaged templates. In contrast, Polγ is unable to enhance PrimPol 
DNA synthesis upon oxidative stress (Stojkovic et al., 2016). 
 
Figure 9. Two possible mechanisms for PrimPol function. The RPA-covered stretch of ssDNA 
generated by a stall fork is likely to recruit PrimPol. Our previous data (Mourón et al., 2013) indicates 
that PrimPol uses its primase activity to reinitiate a new DNA strand ahead of the lesion. Taking into 
account its activities in vitro, PrimPol could also operate as a TLS polymerase and bypass the lesion 
directly. 
4.3. Regulation of PrimPol activity by other factors 
Unlike canonical TLS polymerases, hPrimPol does not interact, nor is it stimulated by, 
unmodified or monoubiquitinated PCNA (Guilliam et al., 2013). As explained before, 
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RPA and mtSSB interact with PrimPol. Both proteins have been shown to suppress de 
novo primer synthesis and impede primer extension by PrimPol in vitro (Wan et al., 
2013; Guilliam et al., 2013). This suggests that in vivo, PrimPol may prime at regions 
where RPA/mtSSB has been displaced by other replication factor, or where 
RPA/mtSSB DNA binding is prevented, for instance, in G4 quadruplex structures. 
Polymerase δ-interacting protein 2 (PolDIP2) was also identified in a pull-down screen 
as a partner of PrimPol (Guilliam et al., 2016). As PrimPol, PolDIP2 is also localized in 
mitochondria and nucleus (Lui et al., 2003; Cheng et al., 2005). This protein stimulates 
the in vitro activity of Polδ and the processivity and fidelity of lesion bypass by Polλ 
and Polη (Xie et al., 2005; Tissier et al., 2013; Maga et al., 2013). Furthermore, 
PolDIP2 interacts also with Polζ and Rev1, although the relevance of this interaction 
remains unknown (Tissier et al., 2013). PolDIP2 enhances PrimPol DNA binding and 
polymerase activity, with a minimal effect on its priming function. Moreover, PolDIP2 
increases the efficiency and fidelity of 8-oxo-G bypass by PrimPol in vitro (Guilliam et 
al., 2016).  
Despite the evident importance of PrimPol in DDT mechanisms, the implications of 
PrimPol in human disease and the consequences of PrimPol ablation in mammals 
remain still under investigated. Therefore, in this thesis we performed (1) structure-
function analyses of PrimPol conserved amino acid that could be implicated in human 
disease and (2) a study of the effects of PrimPol ablation using a PrimPol knock-out 
mouse model. 
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OBJECTIVES 
1. Structure-function analyses in human PrimPol: functional relevance of amino 
acids W87, F88, Y89, Y90, belonging to the evolutionary conserved “WFYY” motif. 
This objective also included a functional validation of the importance of conserved 
Y100 residue. 
2. Characterization of the effects of PrimPol ablation in cells and in a mammalian 
organism: 
2.1. Determine the dynamics of DNA replication and UV-susceptibility in 
PrimPol-deficient mouse embryonic fibroblasts. 
2.2. Study the physiological impact of PrimPol ablation in the mouse, including 
its sensitivity to UV-induced DNA damage. 
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MATERIAL AND METHODS 
1. Mice procedures 
1.1. Ethical statement 
Mice were kept in the Animal Facility at CNIO in accordance with institutional policies 
and the “Federation for Laboratory Animal Science Associations” (FELASA) 
guidelines. All animal procedures were approved by the Animal Experimental Ethics 
Committee of the Instituto Carlos III (Madrid, Spain). 
1.2. Treatment of mice with TPA 
TPA (Sigma-Aldrich) was dissolved in acetone at a concentration of 3.4 nmol/200 μL. 
The dorsal hair of the mice was shaved, 48 h before TPA treatment. 200 μL of TPA 
were applied to the dorsal skin twice per week for 2 weeks. 30 min before euthanasia, 
an i.p. injection of BrdU (100 μg/g body weight) was administered. The back skin was 
subject to histological examination. The degree of hyperplasia was estimated using 
Panoramic Viewer software on images of H&E-stained sections. 
1.3. Treatment of mice with UV radiation 
In the acute irradiation regime, the dorsal hair of mice was shaved 48h before 
administration of a single dose of 3000J/m
2
 UVB in a device using Philips UVB TL 
20W/12 RS lights. Mice were sacrificed at 1, 2, 3, 4 or 5 days post-irradiation. 30 min 
before euthanasia, an i.p. injection of BrdU (100 μg/g body weight) was administered. 
The degree of hyperplasia and cellular density in the dorsal skin were estimated using 
Panoramic Viewer software on images of H&E-stained sections. 
In the chronic UV irradiation regime, the dorsal hair of mice was shaved 48 h before the 
initial UV radiation and once a week thereafter. Mice were irradiated three times per 
week using the same device as for the acute irradiation, but the dose was lowered to 
1800 J/m
2
 UVB. The overall health and external aspect of irradiated mice were 
monitored weekly. Mice were sacrificed at the end of the experiment (or before, if the 
humane endpoint criteria were met), and different tissues (ear, dorsal and tail skin, eyes) 
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were selected for histopathological analyses. The spleen was removed in the necropsies 
and weighed.  
Finally, in the melanoma-inducing protocol, neonates were irradiated in a 6 well-plate 
placed 20 cm beneath the bank of sunlamps (Philips F40 UV lamps). The total radiation 
was 6240 J/m
2
 UVB and 3310 J/m
2
 UVA. After exposure, newborn mice were returned 
to their cages with their mothers. Signs of tumor development or other UV-associated 
morbidity symptoms were monitored weekly. 
1.4. Body temperature and blood analyses 
Body temperature was measured using a Cibertec RTC-1 Thermo Controller rectal 
probe. For blood analysis, mice were anesthetized with isoflurane for the duration of the 
procedure (1-2 min). Blood samples were collected in EDTA-containing tubes (BD 
Microtrainer), and blood cell populations were measured in an Abbacus cell counter. 
1.5. X-ray densitometry 
Body fat percentage was assessed using DEXA scan (PIXImus2; Lunar, Madison, WI). 
Mice were anesthetized with isoflurane for the duration of the procedure (10 min). Each 
mouse was scanned with the limbs and tail stretched away from the body, and the head 
was excluded from the analyses. 
2. Mice genotyping 
Genotyping was performed by PCR analyses of genomic DNA isolated from tail clips 
following a standard protocol (Malumbres et al., 1997). Tails were lysed in PCR-K 
buffer (50 mM KCl, 1.5 mM Tris-HCl pH 8.5, 0.01% gelatin, 0.45% NP-40, 0.45% 
Tween-20, 100 μg/mL proteinase K (Roche)) for 2 h at 55ºC in agitation. Proteinase K 
was inactivated at 95ºC for 15 min. Each PCR reaction was done with 2 μL of Taq 
polymerase (Ecogen), 2.5 μL of 10X Taq reaction buffer (Ecogen), 1.5 μL of 50 mM 
MgCl2 (Ecogen), 1 μL of each primer from a 10 μM dilution in H2O, 1 μL of 10 mM 
dNTPs (Fermentas), and H2O to a final volume of 25 μL. The different primers used for 
mice genotyping are listed in Table 2. 
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Primer name Sequence (5’ 3’) 
OST FW CCTACATCTGCAAGAAGACTTAGC 
OST RV ACACTGGGTCCCTTTACAGATGG 
LTR RV ATAAACCCTCTTGCAGTTGCATC 
Table 2. Primers for mice genotyping. 
 
3. Cell culture experiments 
3.1. Cell lines and manipulations 
The stable cell line shPrimPol-HeLa was generated in the laboratory as part of a 
previous study (Mourón et al., 2013). Expression of PrimPol shRNA was induced with 
1μg/mL doxycycline (dox) for 3 days. DNA sequences encoding wild-type (WT) 
PrimPol, or PrimPol versions AxA (Mourón et al., 2013), W87G, F88L, Y89D, Y90D 
and Y100H were cloned into Gateway expression vectors introducing an N-terminal V5 
tag (Invitrogen). Transient transfections were performed using Lipofectamine 2000 
(Invitrogen). 
PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/- 
MEFs were specifically obtained for this study. All 
cells were grown in complete DMEM (Lonza) supplemented with 10% FBS plus 10% 
penicillin-streptomycin. Cell lines were tested monthly for mycoplasma contamination. 
3.2. Primary Mouse Embryonic Fibroblasts (MEFs) isolation 
Mouse embryos were obtained at E12.5 days. Pregnant females were sacrificed by 
cervical dislocation and uterine horns containing the embryos were transferred to a 
sterile PBS solution in a laminar flow hood. Embryos were collected from the uterus, 
fetal liver was excised and a fragment of tissue was taken for molecular genotyping. 
The rest of embryonic tissue was minced and treated with 0.25% trypsin-EDTA (Sigma-
Aldrich) for 20 min at 37ºC. Cells were further disaggregated by pipetting, transferred 
to 9mL medium (DMEM complete (Lonza), 15% FBS, 10% penicillin/streptomycin 
solution (Invitrogen)), seeded in tissue culture plates and grown at 37ºC and 5% CO2. 
Cells were expanded and frozen at passage 1 in 90% FBS, 10% dimethyl sulfoxide 
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(DMSO, Sigma-Aldrich). All experiment with primary MEFs were performed at low 
passage number (≤ 4). 
3.3. Proliferation curves with MEFs 
Aliquots of 90,000 cells were seeded in 6-well plates in duplicate. After 3 days in 
culture a 1:2 split was performed to avoid confluency. Proliferation rate was estimated 
by counting cells at each time point using a Neubauer hemocytometer. 
3.4. Sister Chromatid Exchange (SCE) analyses 
Exponentially growing cells were labeled for 38h with 10 μM BrdU. Colchicine (0.1 
μg/mL) was added for the last 2h prior to harvesting the cultures. For metaphase spread 
preparation, cells were subjected to an osmotic shock (75 mM KCl for 20 min at 37ºC), 
centrifuged for 10 min at 200g and fixed by drop-wise addition of Carnoy’s fixative 
solution (ice-cold 3:1 methanol:acetic acid). Cells were subjected to 3 cycles of 
centrifugation and Carnoy’s solution addition before storing them at -20ºC. For 
chromosome spreading, microscope slides were soaked in 45% acetic acid and drops of 
the cell suspension were spread on the slide. Slides were then incubated in 0.1M 
phosphate buffer (pH 6.8) containing Hoechst 33258 (Sigma) (0.11 mg/mL) for 20 min 
in darkness. After the exposure of slides to fluorescent light for an hour, the slides were 
digested with disodic phosphate (1M, pH 8) at 88ºC for 5 min and then washed with 
distilled water. After air-drying, chromosomes were stained with 5% Giemsa (Sigma). 
SCE events were scored and normalized to the total number of analyzed chromosomes. 
3.5. Oncogenic transformation assay 
pBabe (empty), pBabe-H-RasV12 and pBabe-H-RasV12/E1A retroviral supernatants 
were produced by calcium phosphate transfection of 293T cells following a standard 
protocol (Wigler et al., 1977). MEFs were grown until near confluency before infecting 
them with the retroviral supernatants. 24h later the medium was changed and 10 days 
post-infection plates were fixed with 1% glutaraldehyde, stained with 0.1% cristal violet 
in 10% ethanol and scored for number of colonies.  
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3.6. Single-molecule analysis of DNA replication in stretched fibers 
DNA fiber spreads were prepared using a published protocol (Terret el al, 2009) with 
slight modifications that are described below. To evaluate the rate of fork progression, 
exponentially growing cells were sequentially pulse-labeled for 20 min with 50 μM 
chlorodeoxyuridine (CldU) and 250 μM iododeoxyuridine (IdU). To evaluate fork 
restart, cells were first pulsed with CldU for 20 min and then irradiated with UVC (30 
J/m
2
) or treated with 6 mM HU (Sigma-Aldrich) for 5h. 30 min after exposure to UV 
light, or immediately after the HU incubation, cells were pulsed with IdU for 20 min in 
fresh medium. Cells were harvested and resuspended in cold PBS at 0.25·10
6
 cells/mL. 
2 μL of cell suspension were placed on a microscope slide and lysed for 6 min in 10 μL 
of pre-warmed (30ºC) spreading buffer (0.5% SDS, 200mM Tris-HCl pH 7.4, 50  mM 
EDTA). Slides were tilted at a 15º angle to allow DNA suspension to run slowly down 
the slide, and the resulting DNA spreads were air-dried, fixed in cold 3:1 methanol: 
acetic acid for 2 min and kept overnight at 4ºC. 
Slides were treated with 2.5 N HCl for 30 min, washed three times in PBS and blocked 
in 1% BSA, 0.1% Triton X-100 in PBS for 1h before incubation with CldU, IdU and 
ssDNA primary antibodies (Table 4) diluted in blocking solution (1/100) for 1h. 
Fluorophore-conjugated secondary antibodies were added for 30 min. ProLong Gold 
antifade reagent (Invitrogen) was used as mounting media for IF.  
Microscopy analysis was carried out using a Leica DFC350 FX microscope. DNA 
staining was used to confirm fiber integrity. Fork progression rate was monitored in 
second-labeled (IdU) tracks. The length of more than 300 tracks was measured per 
condition using ImageJ software and conversion factor 1μm = 2.59kb (Jackson and 
Pombo 1998). To evaluate fork restart, 500 structures (restarted forks and non-restarted 
forks) were counted per condition. The result is shown as the percentage of bicolor 
tracks divided by all the counted structures. 
3.7. Immunofluorescence 
Cells grown on polylysine-treated coverslips were fixed with 4% paraformaldehyde 
(PFA) in PBS for 15 min, permeabilized with 0.5% Triton X-100 in PBS for 5 min and 
treated with blocking solution (3% BSA, 5% normal donkey serum (Jackson 
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ImmunoResearch) and 0.05% Tween-20 in PBS) for 30 min. Primary and fluorophore 
conjugated-secondary antibodies were diluted in blocking solution. The primary 
antibodies used for IF are listed in Table 4. Nuclei were stained with 1 μg/μL DAPI 
(Sigma) in PBS for 1 min. ProLong Gold antifade reagent was used as mounting media 
for IF. For CPD and (6,4)-pp immunodetection, cells were subjected to a pre-extraction 
step with 0.3% Triton X-100 in CSK buffer (10mM PIPES pH 7.0, 0.1M NaCl, 0.3M 
sacarose and 3mM MgCl2 0.5mM PMSF) for 5 min at 4ºC. 
Images were acquired in a Leica DFC350 FX confocal microscope. Image analysis was 
performed at the Confocal Microscopy Unit at CNIO, using pre-designed routines for 
nuclei detection and intensity measurement in the Definiens software (Definiens, 
Germany).  
3.8. Flow cytometry analysis 
For BrdU incorporation analysis, cells were pulse-labeled with 10 μM BrdU for 30 min. 
Cells were trypsinized, washed with PBS and fixed overnight at 4ºC in 70% ethanol. 
DNA denaturation and cell permeabilization was carried out with 2N HCl for 20 min at 
37ºC. Cells were washed twice in PBS for HCl neutralization and incubated for 1 h with 
FITC-BrdU antibody (BD Biosciences Pharmigen) in 1% BSA PBS- 0.05% Tween-20. 
For DNA content analysis, cells were incubated overnight in DNA staining solution (25 
μg/mL propidium iodide (Sigma-Aldrich)), 10 μg/mL RNase A (Qiagen)). 
Data acquisition was carried out in a FACS Canto II cytometer (Becton-Dickinson) and 
data were analyzed using Flow Jo software (Tree Star).  
4. RNA expression analyses 
4.1. RNA isolation, retrotranscription and quantitative PCR (RT-qPCR) 
Tissues were disrupted and homogenized in Trizol (Invitrogen) using a bead-beating 
system (Precellys). Total RNA was isolated according to Trizol manufacturer’s 
instructions. Potential contaminant genomic DNA was removed by DNaseI digestion 
(Roche). 1μg of RNA was converted to cDNA with Maxima First Strand cDNA kit 
(Themo). cDNAs were diluted 1/10 and qPCR was performed in triplicates using SYBR 
green-Real Time PCR master mix (Applied Biosystems). Primers used for RT-qPCR 
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analysis are shown in Table 3. The 2ΔΔCt method was used to quantify amplified 
fragments. Expression levels were normalized to GAPDH housekeeping gene. RT-
qPCR analysis were done using a 7900HT Fast Real Time PCR System equipment and 
analyzed with SDS 2.2.2 Software (Applied Biosystems). 
Gene Primer Sequence (5’ 3’) 
PRIMPOL 
PRIMPOL-FW TAACAAATTGGCCAACCCAGGAG 
PRIMPOL-RV ACCTTAGCTTCATCATCCTCGGC 
GAPDH 
GAPDH-FW GCACAGTCAAGGCCGAGAAT 
GAPDH-RV GCCTTCTCCATGGTGGTGAA 
Table 3. Primer sequences for gene expression analyses by RT-qPCR. 
5. Protein analyses 
5.1. Whole tissue and cell extracts 
Mouse tissues were lysed in RIPA lysis buffer (1% NP-40, 0.1% SDS, 50mM Tris-HCl 
pH 7.4, 150mM NaCl, 0.5% sodium deoxycholate, 1mM EDTA, 1mM NaVO4, 0.5 mM 
NaF, 0.1mM PMSF, protease inhibitors (Roche)) for 20 min on ice and sonicated 
(Branson sonicator 102C) for 30 s at 20% amplitude. Extracts were clarified by high-
speed centrifugation (15min/16000g/4ºC). Protein was quantified using BCA kit 
(Pierce) according to manufacturer’s protocol. 
For whole cell extracts intended for immunoblot analysis, cells were trypsinized, 
collected by centrifugation (1200 rpm, 5 min), washed with PBS and lysed in Laemmli 
Sample Buffer (50 mM Tris-HCl pH 6.8, 10% glycerol, 3% SDS, 0.006% w/v 
bromophenol blue and 5% 2-mercaptoetanol) at 5000 cells/μL and subsequently 
sonicated for 30 seconds at 15% amplitude.  
5.2. Chromatin fractionation protocol 
Biochemical fractionations to separate soluble and chromatin-enriched fractions were 
performed as described (Méndez and Stillman, 2000). Briefly, cells were resuspended at 
2·10
7
 cells/mL in buffer A (10mM HEPES pH 7.9, 10mM KCl, 1.5mM MgCl2, 0.34M 
sucrose, 10% glycerol, 1mM DTT, 1mM NaVO4, 0.5mM NaF, 5mM β-
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glycerophosphate, 0.1mM PMSF, protease inhibitors cocktail (Roche)), and incubated 
on ice for 5 min in the presence of 0.05% Triton X-100. Low-speed centrifugation 
(4min/600g/4ºC) allowed the separation of the cytosolic fraction (supernatant) and 
nuclei (pellet). The cytosolic fraction was clarified by high-speed centrifugation 
(15min/16000g/4ºC). Nuclei were washed with buffer A and subsequently subjected to 
hypotonic lysis in buffer B (3mM EDTA, 0.2mM EGTA, 1mM DTT, 1mM NaVO4, 
0.5mM NaF, 5mM β-glycerophosphate, 0.1mM PMSF, protease inhibitors cocktail 
(Roche)) for 30 min on ice. Nucleoplasmic and chromatin-enriched fractions were 
separated after centrifugation (4min/600g/4ºC). Chromatin was resuspended in Laemmli 
sample buffer and sonicated twice for 30 seconds at 15% amplitude. 
Alternatively, when indicated HeLa cells were lysed and fractionated using a Cell 
Fractionation Kit (MitoSciences ab109719), which allowed the isolation of 
mitochondrial, cytoplasmic and nuclear fractions. 
5.4. Immunoblots 
SDS-polyacrylamide gels and immunoblotting were performed following standard 
protocols (Harlow and Lane, 1999). The primary antibodies used are listed in Table 4. 
Horseradish peroxidase (HRP)-conjugated secondary antibodies (Amersham 
Biosciences) and ECL developing reagent (Amersham Biosciences) were used.  
6. Histological analyses 
Histopathological analysis was performed at the Compared Pathology Unit, CNIO. 
Briefly, tissues were fixed overnight in 10% buffered formaline, embedded in paraffine 
and sectioned (5 μm). Samples were deparaffinized, re-hydrated and stained with 
hematoxylin-eosin (H&E). For immunohistochemistry (IHC) stainings, tissues were 
subjet to antigen retrieval and blocking of endogenous enzymatic activities. Tissue 
slides were digitalized using a Mirax scanner (Carl Zeiss) and equivalent areas per 
tissue and group were analyzed using the AxioVision digital image processing software 
(Carl Zeiss), if necessary. Tumor identification and classification was performed by Dr. 
Alba de Martino (Compared Pathology Unit, CNIO). 
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Antibody Use Supplier Ref/Catalogue # 
(6,4)-pp (64M-2 clone) IF Cosmo Bio Co. NMDND002 
α-fetoprotein IHC R&D Systems AF5369 
α-tubuline WB Sigma T9026 
ATP-synthase WB Abcam AB43176 
BrdU IHC GE Healthcare RPN202 
BrdU-FITC FACS BD-Biosciences BD 556028 
CD3 IHC Santa Cruz Sc-1127 
CD31 IHC Abcam AB28364 
CldU (BrdU-clone BUI/75) IF Abcam AB6326 
CPD (TDM-2 clone) IF Cosmo Bio Co. NMDND001 
CTCF WB Millipore 07-729 
F4/80 IHC ABD Serotec MCA497 
H3 WB Abcam AB1791 
IdU (BrdU-clone B44) IF BD-Biosciences BD 347580 
Mek2 WB BD Transduction 610235 
p53 WB Cell Signaling 9282 
PAX5 IHC Santa Cruz Sc-1974 
hPrimPol WB R. Freire’s lab Mourón et al., 2013 
mPrimPol WB R. Freire’s lab - 
PPARγ WB Cell Signaling 2435 
pS139-H2AX (γH2AX) WB, IHC Millipore 07-164 
pS15-p53 WB Cell Signaling 9284S 
p(S4/S8)-RPA WB Bethyl laboratories A300-245A 
RPA WB Cell Signaling 2208 
SREBP1 WB Abcam AB3259 
ssDNA IF Millipore MAB3034 
V5 epitope tag WB Invitrogen R960-25 
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Vimentin IHC Cell Signaling 5741 
Table 4. Antibodies used in this study 
 
 
7. Biochemical assays (Dr. Luis Blanco’s laboratory data) 
7.1. DNA primase assay 
DNA primase assay of the PrimPol mutants was evaluated using a 29-mer 
oligonucleotide (5’-T15CCTGT10-3’) as template, which contains a putative herpes virus 
priming imitation site (GTCC), as described (García-Gómez et al., 2013). The reaction 
mixture (20μL) contained buffer R (50 mM Tris pH 7.5, 5% Gly, 75 mM NaCl, 1mM 
MgCl2, 1 mM DTT and 0.1 μg/μL BSA), [γ-
32
P]ATP (16 nM; 3000 Ci/mmol), 10 μM 
dGTP and various concentrations of the different mutants (50, 100, 200 and 400nM). 
The reaction was incubated during 60 min at 30ºC. Reactions were stopped by addition 
of formamide loading buffer (10 mM EDTA, 95% v/v formamide and 0.3% w/v xylene-
cyanol) and loaded in 8 M urea-containing 20% polyacrylamide sequencing gels. 
7.2. DNA polymerase activity 
A 15-mer oligonucleotide primer (5’-GATCACAGTGAGTAC-3’) was labeled using 
T4 PNK (New England Biolabs) and [γ-32P]ATP (3000 Ci/mmol), and hybridized to a 
28-mer oligonucleotide template (5’-AGAAGTGTATCTCGTACTCACTGTGATC-3’) 
in 20 mM Tris, 0.5 M NaCl, heated up to 80ºC and cooled down to RT. The resulting 
hybrid had a 5’ protrusion of 13 templating nucleotides. The reaction mixture (20μL) 
contained buffer R (50 mM Tris pH 7.5, 5% Gly, 75 mM NaCl, 1mM MgCl2, 1 mM 
DTT and 0.1 μg/μL BSA) contained 5 nM [γ-32P]ATP-labeled template-primer, 100 μM 
dNTP and different concentration of the different mutants (50, 100 and 200 nM). The 
reaction was incubated during 60 min at 30ºC. Reactions were stopped and analyzed as 
in the DNA primase assay. 
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RESULTS 
Chapter 1: Structure-function analysis of hPrimPol 
1. Analysis of the WFYY motif 
1.1. WxxY is a conserved motif in PrimPol proteins 
Despite the importance of PrimPol in damage tolerance during DNA replication 
(Bianchi et al., 2013; García-Gómez et al., 2013; Wan et al., 2013; Mourón et al., 2013) 
its association with human disease remains largely unknown. Interestingly, a variation 
in the human PrimPol gene (CCDC111) had been identified in a set of patients with 
high myopia (Zhao et al., 2013). Specifically, exome sequencing at candidate patients 
identified a missense mutation (Y89D) in PrimPol protein. Amino acid sequence 
alignment reveals that Tyr89 is part of a conserved motif (WFYY) in higher eukaryotes. 
Nevertheless, extending the sequence alignment to more primitive organisms reveals 
that Tyr89 and Phe88 of the WFYY motif are not conserved in other eukaryotes and 
archaea. In contrast, their neighbor amino acids Trp87 and Tyr90 are highly conserved 
suggesting that this motif may be important for PrimPol function (Figure 10A and 
B).Phe88 and Tyr89 are frequently exchanged for other residues. For this reason, this 
PrimPol motif could be more strictly defined as WxxY. 
The active site of PrimPol includes three negatively charged residues (D114, E116 and 
D280) that are presumably in charge of coordinating the metal activation (Bianchi et al., 
2013; García-Gómez et al., 2013). The WFYY motif is in close proximity to the active 
site. In order to evaluate the importance of this conserved domain, four different 
PrimPol mutants (W87G, F88L, Y89D and Y90D) were generated, including the 
presumed “pathological mutation” in Tyr89. To determine their activity in human cells, 
we have worked with a HeLa-shPrimPol cell line (Mourón et al., 2013) in which a 
shRNA molecule targeting PrimPol mRNA can be induced with doxycycline (dox). As 
shown in Figure 11, addition of dox efficiently downregulated the endogenous PrimPol, 
while exogenous PrimPol (either WT or mutant) was introduced from expression 
plasmid. The expression levels of all PrimPol variants were monitored with PrimPol and 
V5 antibodies, and they were comparable in all cases. 
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Figure 10. The conserved WFYY domain in PrimPol protein. A. Schematics of  hPrimPol showing 
the positions of  conserved active site motifs A, B and C, shared by members of the AEP superfamily, and 
a Zn-finger domain similar to that of herpesvirus UL52 primase; the WFYY motif described in this 
chapter is located next to the motif A. B. Amino acid sequence alignment of the segment that contains 
WFYY motif in different eukaryotic and archaeal PrimPol proteins. The motif could be strictly defined as 
WxxY, the tryptophan (W) is strictly invariant and the tyrosine (Y) is highly conserved in PrimPol 
proteins. Sequence alignment provided by Dr. L. Blanco (CBMSO, Madrid). 
 
Figure 11. PrimPol replacement assay. A. Schematics of the experimental design. B. Immunoblot 
showing expression levels of WT, AxA, W87G, F88L and Y90D PrimPol variants. Downregulation of 
endogenous upon dox treatment is shown in lines 1-2. MEK2 levels are shown as loading control. 
A 
B 
B 
A 
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1.2. Trp87 and Tyr90 are required for PrimPol function in S-phase 
First, the activity of the PrimPol mutant versions was evaluated in unperturbed S-phase 
using stretched DNA fibers. This approach allows the visualization of newly 
synthesized DNA tracks at the single molecule level. To perform this experiment, living 
cells were sequentially pulse-labeled with halogenated nucleosides 5-cloro-
deoxyuridine (CldU) and 5-iodo-deoxyuridine (IdU). After this, genomic DNA was 
extracted and stretched onto glass slides, stained with IdU and CldU-specific antibodies, 
and visualized by immunofluorescence (IF) microscopy. The configuration of 
replication tracks on single DNA molecules allows the identification of origins, ongoing 
forks, stalled forks, termination and even re-replication events (Figure 12A and B) 
(Dorn et al., 2009; Técher et al., 2007). As previously reported (Mourón et al., 2013), 
PrimPol downregulation led to a decrease in fork rate. This reduction was caused by the 
absence of PrimPol since it could be reverted by reintroduction of exogenous WT-
PrimPol. In contrast, reintroduction of a catalytically inactive PrimPol in which the two 
carboxylate residues Asp114 and Glu116 have been mutated to alanine (AxA-PrimPol; 
García-Gómez et al., 2013) did not rescue the phenotype. This “PrimPol replacement” 
method was used to assess the activity in vivo of W87G, F88L, Y89D and Y90D 
PrimPol variants. W87G and Y90D mutants did not rescue the loss of endogenous 
PrimPol, whereas F88L and Y89D restored the fork rate to the same extent as WT-
PrimPol (Figure 13). This initial result suggests an important role for residues W87 and 
Y90 in PrimPol activity. 
 
Figure 12. Replication structures detected by DNA fiber spreading. A. Microscopy image of stretched 
DNA fibers derived from cells sequentally labeled with CldU (red) and IdU (green). Yellow arrows 
indicate IdU tracks from ongoing forks, normally used to measure FR values. A ssDNA antibody (grey) 
was used to monitor the integrity of the DNA fibers. Scale bar, 10 μm. B. Representative pictures of the 
types of structures that can be identified with this technique. 
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Figure 13. PrimPol Trp87 and Tyr90 are required to maintain the replication fork rate in S-phase. 
A. Workflow of the experiment. After the introduction of exogenous PrimPol (48h), cells were incubated 
with CldU (red) and IdU (green) and stretched DNA fibers were obtained. B. Representative pictures of 
the DNA fibers before and after dox treatment. Scale bar, 10 μm. C. FR values calculated from stretched 
DNA fibers. Reduction of endogenous PrimPol causes significant drop in FR. The capacity of V5-tagged 
WT, AxA or different PrimPol mutants to complement the absence of endogenous PrimPol was 
estimated. N forks >300; n.s.: non-significant; ***p<0.001 (Mann-Whitney test). 
1.3. Trp87, Phe88 and Tyr90 are necessary for PrimPol function in response to 
UV-induced DNA damage 
Next, we used a variation of the DNA fiber assay to monitor the progression of 
replication forks through specific challenges. HeLa-shPrimPol cells were pulse-labeled 
with CldU (20’) and irradiated with UV light (30J/m2) before pulse-labeling with IdU 
(20’). In this setting, forks arrested by UV irradiation should have incorporated only the 
A 
B 
C 
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first analog, whereas those that continued DNA synthesis should be labeled with both 
analogs (Figure 14A and B). As previously reported (Mourón et al., 2013), loss of 
PrimPol markedly reduced the percentage of forks displaying continuous synthesis. This 
phenotype was fully reversed by cotransfection of a plasmid encoding WT PrimPol, but 
not the AxA catalytic variant. When the new mutants were tested in this assay, we 
found that Y89D variant restored the loss of endogenous PrimPol to the same extent of 
the WT version, whereas W87G, F88L and Y90D PrimPol mutants did not (Figure 
14C). Therefore, amino acids W87 and Y90 (as seen before), but also F88, play a role in 
the function of PrimPol in response to UV radiation.  
Figure 14. Trp87, Phe88 and Tyr90 residues are necessary to reprime UV-stalled forks. A. 
Workflow of the experiment. After the introduction of exogenous PrimPol (48h), cells were incubated 
with CldU (red) before a single irradiation with UV (30 J/m
2
). After 30 min, cells were incubated with 
IdU (green) and stretched DNA fibers were obtained. B. Representative picture of DNA fibers. A 
restarted (R) fork and a non-restarted fork (NR) are marked with yellow arrows. Scale bar, 10 μm..C. 
Quantification of the percentage of fork restart upon UV-irradiation in HeLa-shPrimPol cells with or 
without dox treatment. N structures= 500. One-way ANOVA, Bonferroni Post-test were applied, 
***p<0.0001, n.s: non-significant. Reduction of endogenous PrimPol reduces the fraction of rescued 
forks. The capacity of V5-tagged WT, AxA or the indicated PrimPol versions to rescue the phenotype 
was assessed. 
A 
B 
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Because PrimPol contributes to restart DNA synthesis also after exposure to HU, an 
ribonucleotide reductase inhibitor that reduces cellular dNTP levels (Mourón et al., 
2013), we next tested the WFYY mutants in a dork rescue assay after HU treatment 
(Figure 15A). As it happened with UV radiation, mutants W87G, F88L and Y90D 
failed to rescue the loss of WT PrimPol whereas Y89D did not, validating that Trp87, 
Phe88 and Tyr90 are critical for PrimPol function in fork restart (Figure 15B). 
 
Figure 15. Trp87, Phe88 and Tyr90 residues are necessary to reprime HU-stalled forks. A. 
Workflow of the experiment. After the introduction of exogenous PrimPol (48h), cells were incubated 
with CldU (red) before a single irradiation with HU (5 mM) during 6 hours. Then, cells were incubated 
with IdU (green) and stretched DNA fibers were obtained. B. Histograms show the quantification of the 
percentage of fork restart upon HU treatment in HeLa-shPrimPol cells with or without dox treatment. N 
structures= 500. One-way ANOVA, Bonferroni Post-test were applied, ***p<0.0001, n.s: non-significant. 
Reduction of endogenous PrimPol reduces the fraction of rescued forks. The capacity of V5-tagged WT, 
AxA or the indicated PrimPol versions to rescue the phenotype was assessed. 
1.4. Mutations in WFYY motif does not alter PrimPol subcellular distribution 
In HeLa cells, PrimPol protein is distributed in nucleus, mitochondria and cytoplasm 
(García-Gómez et al., 2013). To rule out the possibility that the inactive mutants could 
display an inappropriate in vivo distribution, the levels of PrimPol were tested in each 
subcellular compartment after biochemical fractionation (Figure 16). WT V5-tagged  
PrimPol was also used to evaluate any possible effect of the tag in the subcellular 
distribution. Importantly, none of the mutants showed an abnormal distribution. 
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Therefore, the effects observed in the stretched DNA fibers experiments are the 
consequence of defects in protein activity rather than a deficient subcellular distribution. 
 
Figure 16. Mutations in the WFYY motif do not alter the subellular localization of PrimPol. A. 
Schematic of the biochemical fractionation (See Methods). B. Immunoblots showing the levels of the 
indicated proteins in whole cell extract (WCE), cytosol (C), mitochondria (M) and nuclear (N) fractions. 
MEK2, ATP-SYNTHASE (ATP-SYNT) and H3 were used as controls of the biochemical fractionation. 
1.5. Trp87 and Tyr90 are essential for the primase and polymerase activities of 
PrimPol 
The in vivo data described previously indicates that Trp87 and Tyr90 are important for 
all PrimPol activities tested, and Phe88 also required for fork restart after UV or HU 
challenge. In collaboration with Dr. Luis Blanco’s laboratory (CBMSO, Madrid) the 
biochemical activity of the same PrimPol variants were assessed in vitro. In perfect 
concordance with the in vivo data W87G and Y90D PrimPol point mutants were 
completely inactive for their primase activity. F88L PrimPol variant shows a modest 
primase activity, while the “pathological mutant” Y89D was active (Figure 17A). 
Similar results were obtained when the DNA polymerase activity was tested in vitro. 
A 
B 
   Results  
55 
 
W87G and Y90D were inactive, F88L was active but less functional than the WT 
version and Y89D mutant was fully active in this primer elongation assay (Figure 17B). 
 
Figure 17.  Trp87 and Tyr90 are essential for hPrimPol primase and polymerase activities. A. 
Primase assay using an oligonucleotide containing a primase-preferred sequence (GTCC). Labeled (γ-
32P)-ATP was provided as the 5’ nucleotide and dGTP as the 3’ nucleotide. hPrimPol forms the expected 
A*G product which is subsequently expanded by reiterative insertion of dG. B. Running star DNA 
polymerization by hPrimPol. Primer elongation is measured by changes in the labeled primers mobility 
(Biochemical data obtained from Dr. Luis Blanco laboratory (CBMSO, Madrid). 
1.6. WFYY motif is necessary for DNA-enzyme-dNTP preternary complex 
formation 
The formation of stable complexes between PrimPol and its substrates (DNA and 
dNTPs) can be assessed by Electrophoretic Mobility Assay (EMA). PrimPol is able to 
form a complex with ssDNA and an incoming nucleotide (Figure 18A). Preternary 
complex (enzyme-DNA-dNTP) formation was affected by mutations in the WFYY 
motif. F88L and Y89D could perform the formation of the preternary complex, 
although less efficiently than WT PrimPol. W87G and Y90D were defective in the 
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formation of the complex because they cannot bind the incoming 3’ nucleotide (Figure 
18B). All the mutants were able to bind DNA to the same extend ruling out the 
possibility of unappropriated preternary complex formation due to DNA binding 
alterations (Figure 19). 
 
Figure 18.  Role of the WFYY motif in the interaction of hPrimPol with DNA and nucleotides. A. 
hPrimPol forms a stable preternary complex with ssDNA and an incoming 3’ nucleotide. left panel: 
binary complex of hPrimPol with labeled ssDNA (E:DNA*); both 5’ nucleotide (primer) and 3’ 
nucleotide (incoming) binding sites are empty. Right panel: Mn
+2
-dependent detection of a preternary 
complex (E: DNA:dG*); the 3’nucleotide now occupies its position. B. Preternary complex formation by 
WT or mutant hPrimPol was determined by EMSA (Biochemical data obtained from Dr. Luis Blanco 
laboratory (CBMSO, Madrid). 
 
Figure 19. Alterations in the WFYY motif did not impair DNA binding. Electrophoretic mobility 
shift assay (EMSA) showing a stable interaction of hPrimPol with labeled ssDNA, which is not affected 
by any of the investigated mutations at the WFYY motif. The positions of the free DNA and the DNA-
PrimPol complex (E-DNA*) are indicated. (Biochemical data obtained from Dr. Luis Blanco laboratory 
(CBMSO, Madrid). 
In summary, conserved WFYY motif is necessary for the formation of the preternary 
complex (E:DNA:dNTP) in the active site entrance channel and therefore for the 
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primase and polymerase acitvities of PrimPol. Remarkably, Y89D seems to be a fully 
active PrimPol variant. Therefore, its participation in the etiology of myopia needs to be 
revised (see Discussion). 
2. Tyr100 in hPrimPol 
Alterations in PrimPol found in human cancers are normally mutations or homozygous 
deletions. The most common PrimPol mutations in cancer (L79R, L96I, R417L/W and 
H426N) produce the loss of PrimPol catalytical activity (Calvo and Blanco, unpublished 
results). We have paid special attention to one particular mutation in cancer (Y100H) 
because Tyr100 is a highly conserved residue in eukaryotic PrimPol (Figure 20A). This 
amino acid is located next to the A motif of PrimPol. Besides this, alignment with other 
AEP primases shows that primases that insert only NTPs, such as Prim1, have a His in 
the steric gate, whereas those capable of inserting dNTPs possess a Tyr in this position 
(Figure 20B). Therefore, we decided to analyze whether this change detected in a cancer 
cell might influence affinity for the sugar moiety. Indeed, the in vitro biochemical 
characterization of the Y100H mutant performed by Dr. Luis Blanco laboratory 
(CMBSO, Madrid) indicates that the primase and polymerase activities are preserved 
but with a change in sugar discrimination, as it preferentially insert NTP over dNTPs 
(Figure 21).  
 
Figure 20. Tyrosine 100 of hPrimPol protein is a highly conserved residue in eukaryotic PrimPol. 
A. Tyr100 that appears to be mutated in a cancer cell line is located next to the active site in the A motif. 
This Tyr100 is highly conserved in high eukaryotes. B. Tyrosine is conserved in proteins which insert 
preferentially dNTPs and histidine is preserved in PolDom which inserts mainly rNTPs. 
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Figure 21.  Y100H PrimPol point mutations is fully active but changes the sugar discrimination 
from dNTPs to NTPs. A. Primase assay using an oligonucleotide containing a primase-preferred 
sequence (GTCC). Labeled (γ-32P)-ATP was provided as the 5’ nucleotide and dGTP as the 3’ nucleotide 
(dGTP or GTP as indicated). hPrimPol forms the expected A*G product which is subsequently expanded 
by reiterative insertion of dG. B. Running star DNA polymerization by hPrimPol. Primer elongation is 
measured by changes in the labeled primers mobility. In left panel the 3’ nucleotide was dNTP whereas in 
the right panel was NTP. (Biochemical data obtained from Dr. Luis Blanco laboratory (CBMSO, 
Madrid).  
We have assessed the capacity of Y100H PrimPol to ensure proper fork progression in 
unperturbed S-phase using stretched DNA fibers. As shown in Figure 22, addition of 
dox efficiently downregulated the endogenous PrimPol, while exogenous PrimPol 
(either WT or mutant) was introduced from expression plasmid. The expression levels 
of all PrimPol variants were monitored with PrimPol and V5 antibodies, and they were 
comparable in all cases. Expression of V5-Y100H after ablation of endogenous PrimPol 
in HeLa-shPrimPol cells can restore the FR values to the same extent than the wild-type 
version (Figure 23).  
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Figure 22. PrimPol replacement assay. A. Schematics of the experimental design. B. Immunoblot 
showing expression levels of WT, AxA, W87G, F88L and Y90D PrimPol variants. Downregulation of 
endogenous upon dox treatment is shown in lines 1-2. MEK2 levels are shown as loading control. 
 
 
Figure 23. Y100H PrimPol mutant can maintain the replication fork rate in S-phase. A. Workflow 
of the experiment. After the introduction of exogenous PrimPol (48h), cells were incubated with CldU 
(red) and IdU (green) and stretched DNA fibers were obtained. B. FR values calculated from stretched 
DNA fibers. Reduction of endogenous PrimPol causes significant drop in FR. The capacity of V5-tagged 
WT, AxA or Y100H PrimPol mutant to complement the absence of endogenous PrimPol was estimated. 
N forks >300; n.s.: non-significant; ***p<0.001 (Mann-Whitney test). 
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Y100H-PrimPol variant also displayed the ability to restart forks arrested with HU to 
the same extend as WT-PrimPol variant suggesting (Figure 24), that this specific point 
mutation does not compromise the in vivo function of hPrimPol. However, whether the 
change in dNTP/NTP preference introduces any problem related to genomic instability 
remains to be evaluated.  
 
Figure 24. Y100H PrimPol variant can reprime HU-stalled forks. A. Workflow of the experiment. 
Workflow of the experiment. After the introduction of exogenous PrimPol (48h), cells were incubated 
with CldU (red) before a single irradiation with HU (5 mM) during 6 hours. Then, cells were incubated 
with IdU (green) and stretched DNA fibers were obtained. B. Histograms show the quantification of the 
percentage of fork restart upon HU treatment in HeLa-shPrimPol cells with or without dox treatment. N 
structures= 500. Reduction of endogenous PrimPol reduces the fraction of rescued forks. The capacity of 
V5-tagged WT or Y100H PrimPol versions to rescue the phenotype was assessed. 
Altogether, Tyr100 of PrimPol is an important residue for sugar discrimination. The 
change of this amino acid for a His favors the introduction of NTPs instead of dNTPs. 
This residue change seems not to affect the activity in vivo observed at the single 
molecule level. 
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Chapter 2: A PrimPol KO mouse model 
1. PrimPol is ubiquitously expressed in mouse tissues 
To obtain information about PrimPol expression in the mouse, we quantitatively 
assessed PrimPol mRNA levels by RT-qPCR in different organs extracted from 12-
week-old wild-type mice. PrimPol mRNA levels were normalized to the expression 
levels of housekeeping gene GAPDH. We observed that PrimPol was expressed in all 
tested organs (Figure 25). The highest expression levels were detected in the skin, bone 
marrow, spleen and gastrointestinal tissues. Notably, expression levels were lower in 
muscle and liver, despite their abundance in mitochondria. We conclude from this 
analysis that PrimPol is ubiquitously expressed in the tissues of healthy young mice. 
 
Figure 25. Ubiquitous expression of PrimPol in young mice. PrimPol expression levels were 
quantified by RT-qPCR on total RNA isolated from the indicated organs. PrimPol mRNA levels were 
normalized to GAPDH gene expression. Histogram represents expression as fold change, calculated on 
the average PrimPol levels in four mice relative to expression in the liver (n=4, 2 male and 2 female; 12 
weeks old). 
2. PrimPol
-/-
 mouse model 
In order to study the role of PrimPol in vivo, we obtained a KO PrimPol mouse model 
generated by “gene-trap” (Texas A&M Health Science Center Institute of Biosciences 
and Technology). In this model, the insertion of a gene trap cassette in the 5’-UTR of 
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murine PrimPol gene disrupts gene expression (Figure 26A). The gene-trap allele is 
subsequently referred as PrimPol
-
. After the original mouse line was introduced by 
embryo rederivation into the CNIO Animal Facility, the genetic background was 
enriched in C57BL/6 by continued intercrosses with pure C57BL/6 mice. Genotype was 
routinely confirmed by genomic PCR (Figure 26B). 
Both PrimPol
+/-
 and PrimPol
-/-
 mice were viable and born at Mendelian rates, viable and 
fertile (Figure 26C). Neither PrimPol
+/-
 nor PrimPol
-/-
 male or female mice displayed 
any indication of reduced fertility (Figure 26D). 
 
Figure 26. A viable strain of PrimPol-deficient mice. A. Gene-trap insertion in the 5’-UTR generates a 
knock-out allele in the murine PrimPol gene. B. Left. Three-primer genotyping strategy from genomic 
DNA yields a 340 bp product in the wt PrimPol allele and a 200 bp product in the null allele. Right, 
genotyping of one mice of each genotype (PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
). C. Expected and 
obtained percentages of PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 newborn after PrimPol
+/-
 x PrimPol
+/-
 
breeding showing that PrimPol
-/-
 mice are born at Mendelian rates. D. PrimPol
-/- 
mice are fertile. 
Histogram shows the average litter size and standard deviation of the indicated crosses. The genotypes of 
the paretns (WT, HET and KO) and the number of litters scored of each type of cross are indicated (n). 
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The complete ablation of PrimPol expression was confirmed by protein immunoblots in 
mouse embryonic fibroblasts (MEFs) and bone marrow derived from PrimPol
-/-
 mice 
(Figure 27). We also noticed a downregulation in the endogenous PrimPol levels in the 
heterozygous mice (Figure 27A and B). PrimPol levels were downregulated in 
PrimPol
+/-
 and undetectable in PrimPol
-/-
 cell extracts. Notably, the antibody used for 
the murine extracts seems to be more specific in bone marrow than in MEFs. 
  
Figure 27. PrimPol levels in MEFs and bone marrow. A. PrimPol protein levels in PrimPol+/+, 
PrimPol+/- and PrimPol-/ MEFs as determined by immunoblots. Arrow marks the specific band 
corresponding to murine PrimPol. MEK2 was used as a loading control. B. PrimPol protein levels in 
PrimPol+/+, PrimPol+/- and PrimPol-/- bone marrow from three mice of each genotype as determined by 
immunoblots. MEK2 was used as a loading control.  
2.1. DNA replication and cell proliferation in PrimPol
-/-
 primary cells 
In human tumoral cell lines and in avian cells loss of PrimPol slows down proliferation 
rate and induces replicative stress and genomic instability (Mourón et al., 2013; Wan et 
al., 2013; Bianchi et al., 2013). In contrast, the effects of PrimPol ablation had not been 
established in primary mammalian cells. PrimPol
+/-
 were not affected in their 
proliferation rate, but PrimPol
-/-
 MEFs proliferated at a slower rate in culture (Figure 
28A). The global efficiency of DNA synthesis, assessed by BrdU incorporation was not 
affected, but PrimPol deficient cells presented a slight accumulation in G2/M 
population (Figure 28B). To monitor the presence of replicative stress, we evaluated the 
levels of γH2AX and p-(S4/S8)RPA proteins by immunoblot. No differences were 
found in these RS markers. However, we observed that PrimPol
-/-
 MEFs displayed 
higher levels of endogenous p53 (Figure 28C) which may contribute to the 
accumulation of cells in G2/M and the reduction in proliferation rate. Moreover, 
PrimPol
-/-
 MEFs displayed lower FR values (Figure 28D; Mourón et al., 2013) 
suggesting that the lack of PrimPol compromises the normal DNA replication. 
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Figure 28. Mild effects in cell proliferation in PrimPol-deficient MEFs. A. Proliferation curves of 
PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/- 
MEFs (n = 3 experiments, error bars present to SD). B. Immunoblot 
for p-RPA, RPA (total), p-p53, p53 (total) and  γH2AX. MEK2 was used as loading control. C. BrdU 
incorporation profiles in PrimPol
+/+
 and PrimPol
-/- 
MEFs analyzed by flow cytometry (upper part). Cells 
were pulse-labeled with BrdU for 30 min and stained with PI for DNA content. (lower part) 
Quantification of the cell cycle distribution of 4 different clones of PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/- 
MEFs. Error bars present SD. *p<0.05. D. FR values calculated from stretched DNA fibers. PrimPol 
ablation causes significant drop in FR. Black line indicates the median. N forks >300; n.s.: non-
significant; ***p<0.001 (Mann-Whitney test; Part D extracted from Mourón et al., 2013). 
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2.2. PrimPol deficiency affects the homologous recombination rate in MEFs 
Upon fork collapse, replication can be rescued by a priming event downstream of the 
lesion, in the absence of PrimPol this pathway is compromised (Mourón et al., 2013; 
Wan et al., 2013; Bianchi et al., 2013). In single-molecule analysis of DNA replication, 
PrimPol deficient MEFs displayed short labeled-tracks (Mourón et al., 2013). However, 
flow cytometry analysis of cell cycle and proliferation curves do not reflect an extensive 
problem, which could indicate that stalled forks are rescued by template switching (TS) 
mechanisms (reviewed in Pertmann and Helleday, 2010; Branzei, 2011). If this was the 
case, crossover events should be visualized as sister chromatid exchanges (SCE) on 
metaphase chromosomes (Sonoda et al., 1999). Cells were labeled for 38hwith BrdU 
and BrdU incorporation was visualized on metaphase chromosomes by light 
microscopy (Figure 29A). The frequency of SCE events was found to be higher in 
PrimPol
-/-
 MEFs (Figure 29B). This result has implications in the role of PrimPol in the 
choice between mechanisms of damage tolerance (see Discussion). 
 
Figure 29. PrimPol deficiency increases SCE. A. Representative pictures of metaphase spreads in 
PrimPol
+/+
 and PrimPol
-/- 
MEFs. B. Quantification of SCE events in PrimPol
+/+
 and PrimPol
-/- 
MEFs (n=3 
experiments) *p<0.05. 
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2.3. Primpol loss sensitizes cells to UV-radiation 
In human tumor cell lines challenged with UV radiation, PrimPol is facilitating the start 
of stalled forks via its interaction with RPA (Mourón et al., 2013; Wan et al., 2013). 
Therefore, we decided to characterize in more detail the possible protective role of 
PrimPol to UV radiation.  
 
 
We first confirmed that PrimPol is recruited onto chromatin in UV-challenged MEFs. 
Indeed, 3h after irradiating cells with UV (30J/m
2
), the fraction of PrimPol protein with 
the chromatin increased in comparison to untreated cells (Figure 30A). Next, we 
monitored the presence of γH2AX, p-(S4/S8)RPA and p-(S15)p53 and the total levels 
of these proteins by Western-Blot 8h after challenging the cells with UV. In untreated 
conditions there was a slight increase in total p53 in PrimPol
-/-
 MEFs which could 
reflect the mild proliferative problem (Figure 30B). This increase was more prominent 
after UV irradiation and was accompanied by the detection of p-(S15)p53 (Figure 30B). 
In addition, PrimPol
-/-
 MEFs displayed lower BrdU incorporation 8h after UV 
challenge, although this problem is solved at later time points probably by 
compensatory mechanisms (Figure 31A and B). 
Figure 30. PrimPol is necessary to UV-induced 
DNA damage. A. PrimPol is recruited to chromatin 
upon UV irradiation. Immunoblots showing the 
levels of PrimPol with or without UV treatment. 
WCE: Whole Cell Extract. Tubulin was used as 
loading control in WCE and as a control of efficient 
chromatin fractionation. CTCF was used as a 
loading control in the chromatin-enriched fraction. 
B. Hyperactivation of the DNA damage response 
(DDR) upon UV irradiation (5J/m
2
; 8h) in PrimPol
-/- 
MEFs. Immunoblots showing the levels of p-p53, 
total p53, p-RPA, total RPA, γH2AX. MEK2 was 
used as a loading control. 
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Figure 31. Schematics of the experiment. A. Structures of DNA lesions induced by UV light. B. 
Workflow of the experiment. After UV irradiation (5J/m
2
; 8h), cells were fixed and immunostained with 
α-CPD or α-(6,4)pp (see Methods). C. Immunoblot showing hPrimPol levels before and after dox 
treatment in HeLa-shPrimPol cells. MEK2 was used as loading control.  
 
The most common DNA lesions induced by UV are pyrimidine dimers, CPD and (6,4)-
pp, both of which can stall the progression of replication forks (Figure 31A). If these 
lesions are not properly repaired, forks can collapse leading to double strand breaks 
formation (reviewed in Muñoz and Méndez, 2016). PrimPol is capable of bypassing 
these two types of lesions in vitro (Mourón et al., 2013), although there is no 
information about the possibility of bypassing these lesions in vivo. Therefore, we have 
evaluated the persistence of pyrimidine dimers after UV irradiation. For technical 
reasons related to antibody specificity, these assays were conducted in HeLa-shPrimPol 
cells (Figure 31B and C). We observed that the absence of PrimPol produces an 
accumulation of CPDs and (6,4)-pp lesions in good agreement with the in vitro data 
(Figure 32 and 33). Notably, (6,4)-pp staining shows high levels of background as 
observed in the untreated conditions. 
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Figure 32.  PrimPol-deficient cells accumulate (6,4)-pp lesion after UV irradiation. A. Representative 
IF images showing (6,4)-pp levels in the cell nuclei after UV irradiation. B. Quantification of the intensity 
of (6,4)-pp nuclear staining (n>273 nuclei in each condition). ***p<0.001 (Mann-Whitney test). 
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Figure 33.  PrimPol-deficient cells accumulate CPD lesion after UV irradiation. A. Representative IF 
images showing CPD levels in the cell nuclei after UV irradiation. B. Quantification of the intensity of 
CPD nuclear staining (n=262 nuclei in each condition). n.s.: non-significant; ***p<0.001 (Mann-Whitney 
test). 
Altogether, the experiments with cells in culture suggest that PrimPol plays a protective 
role to UV-induced DNA damage. The lack of PrimPol promotes the hiperactivation of 
p53, problems with the DNA synthesis and the accumulation of pyrimidine dimers after 
UV. In chapter 3, the UV-susceptibility of PrimPol mice will be reported in detail. 
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2.4. PrimPol loss facilitates cell transformation 
It is not yet clear whether PrimPol acts as oncogene or a tumor suppressor. We tested 
how the absence of PrimPol affected cell transformation in primary MEFs transfected 
with H-RasV12 and E1A. In this classic “colony transformation” assay, PrimPol-/- 
showed enhanced transformation suggesting that PrimPol may be acting as a tumor 
suppressor gene (Figure 34A and B). 
 
Figure 34. Enhanced oncogenic transformation in PrimPol deficient MEFs. A. Colony formation 
assay in primary MEFs (PrimPol
+/+
 and PrimPol
-/-
) transfected with H-RasV12/E1A or with empty vector 
(EV). B. Quantification of colonies per plate in PrimPol
+/+
 and PrimPol
-/-
 MEFs. (n= 3 plates ) **p<0.01.  
2.5. PrimPol
 
deficient mice show mild lymphopenia 
As described in Figure 26, PrimPol
-/-
 mice were born at Mendelian rates and were 
viable. A small set of mice (n=4, 2 males and 2 females) were sacrificed at 12 weeks of 
age to monitor any possible abnormalities. While the necropsy analysis did not reveal 
any major phenotype, analysis of blood revealed a mild lymphopenia in PrimPol
-/-
 mice, 
since they presented lower levels of circulating lymphocytes (Figure 35A). IHC staining 
of spleen sections showed an increase in DNA damage marker γH2AX, although it did 
not reach statistically significance (p=0.14) (Figure 35B). Despite these mild effects in 
young PrimPol-deficient mice, the animals remained healthy and did not show any signs 
of morbidity in their youth (see below). 
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Figure 35. Mild lymphopenia in young PrimPol deficient mice.  A. Quantification of lymphocytes, red 
blood cells and platelets in circulating blood of mice of the indicated genotypes (n = 15 PrimPol
+/+
, 18 
PrimPol
+/-
 and 17 PrimPol
-/- 
mice). *p<0.05, n.s.= non-significant. B. Left, spleen sections immunostained 
with γH2AX. Right, quantification of the percentage of positive cells for γH2AX (n=3). 
2.6. PrimPol
 
deficiency in longevity studies 
To determine the long-term phenotypic effects of PrimPol ablation in vivo, cohorts of 
PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice were arranged for ageing/longevity studies. 
Mice were monitored routinely and sacrificed at the human endpoint following 
regulations established by the Animal Experimental Ethics Committee (Instituto de 
Salud Carlos III). Kaplan-Meier survival curves indicated that PrimPol
-/-
 animals had a 
mean overall lifespan of 94 weeks, lower than their wt and PrimPol
+/-
 littermates (110.5 
and 110, respectively) (Figure 36). All mice in this study were subject to 
histopathological examination in collaboration with Dr. Alba de Martino (Head, CNIO 
compared pathology). In the following sections we summarize the phenotypic findings 
associated to ageing and the results of the histopathology examinations. 
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2.6.1. PrimPol
+/+
 and PrimPol
+/-
 display signs of alopecia and ocular ulcers 
PrimPol
+/-
 and PrimPol
-/-
 mice presented a higher degree of alopecia than PrimPol
+/+
 
littermates (Figure 37A). For unknown reasons, this phenotype was more prevalent in 
females (Figure 37B). Anatomopathological analysis of skin sections revealed the 
presence of “folded follicles”, aberrant structures in which excessive keratinization 
prevents the release of hair from the follicle. This analysis also revealed the atrophy of 
sebaceous glands accompanied by a recruitment of mast cells (Figure 37C).  
 
Figure 37. PrimPol deficient mice develop alopecia. A. Representative images of the grade of the hair 
loss observed in PrimPol
-/- 
 mice at 72 weeks old. B. Histograms show the percentage of total mice with 
alopecia in the ageing study. The results are also shown separated by gender. C. Representative section of 
Figure 36. Reduced lifespan after PrimPol ablation in 
vivo. Kaplan-Meier curves for control (black), PrimPol
+/-
 
(red) and PrimPol
-/- 
(green) mice. 24 individuals were 
included in each group. *p<0.05.  
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the skin from PrimPol
+/-
 and PrimPol
-/- 
females mice stained with H&E. Folded follicle (left), atrophic 
sebaceous gland (middle) and mast cells infiltration indicated with black arrows (right). 
Besides the hair loss phenotype, higher frequency of ocular ulcers was observed in 
PrimPol
+/-
 and PrimPol
-/-
 mice that again, it seemed to be gender-specific being more 
frequent in females (Figure 38A and B).  
 
Figure 38. PrimPol deficient mice present higher incidence of ocular ulcers. A. Representative 
images of two ulcers in PrimPol
-/- 
mice. B. Histograms show the percentage of total mice with ocular 
ulcers in the ageing study (right) and the percentage of females with ocular ulcers.  
2.6.2. PrimPol deficient mice are prone to obesity 
In addition, during the longevity studies we realized that old PrimPol
-/-
 mice weighted 
more than their littermates (Figure 39A and B). This obesity became apparent at 90 
weeks old and correlated with a higher percentage of body fat as determined by X-ray 
densitometry (Figure 39C).  
Other mouse models defective for DNA repair enzymes have been associated with 
problems in body weight homeostasis (see Discussion). The specific mechanisms that 
link genome instability to metabolic syndrome have not been elucidated yet. In this 
study, we have also evaluated whether any symptom related to defective metabolism 
could be detected in young PrimPol-deficient mice.  First we evaluated the percentage 
of body fat by X-ray densitometry and did not observe significant differences among the 
three genotypes (Figure 40A). The expression of the master adipogenic regulator genes 
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SREBP1 and PPAR-γ was similar in PrimPol+/+, PrimPol+/- and PrimPol-/- mice (Figure 
40B).  
Figure 39. Obesity in old PrimPol deficient mice. A. Representative images of young (12 yo) and old 
(90 wo) PrimPol
+/+
 and PrimPol
-/-
 mice. B. Histogram quantification of body weight at the indicated time 
points in PrimPol
+/+
 and PrimPol
-/-
 mice. C. Representative X-ray densitometry images in PrimPol
+/+
 and 
PrimPol
-/-
 mice. D. Quantification of the percentage of body fat PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 90-
week-old mice (n= 14 PrimPol
+/+
, 10 PrimPol
+/-
 and 11 PrimPol
-/-
). *p<0.05, **p<0.01.  
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Figure 40. PrimPol deficient young are not obese. 
A. Representative X-ray absorption images in 
PrimPol
+/+
 and PrimPol
-/-
 mice (Upper part). 
Quantification of percenatge of body fat in males (n= 
6; middle part) and females (n=5; lower part). B. 
Immunoblot detection of SREBP1 and PPARgamma 
in WAT extracts from mice of the indicated genotype 
(n=3 mice per genotype). MEK2 was used as loading 
control. 
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Next, we evaluated adipocyte size in white adipose tissue (WAT) and brown adipose 
tissue (BAT) of 20-week-old mice PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
. While no 
differences were seen in WAT (Figure 41A, B and C), unexpectedly we observed that 
PrimPol
-/-
 had smaller BAT adipocytes (Figure 42A, B and C). As BAT is crucial for 
temperature regulation in rodents, we evaluated the body temperature in these mice. 
Although the differences did not reach statistically significance, PrimPol
-/-
 mice 
displayed slightly lower temperature consistent with an atrophic BAT (Figure 43).  
 
Figure 41. Normal adipocyte size in youn PrimPol-deficient mice. A. Representative WAT sections 
(H&E) from PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice. Scale bar, 50μm B. Adipocyte cell size 
quantification (n=4 animals per genotype). Red bars indicate the median values. 400 adipocytes were 
measured per mouse. C. Adipocyte cell size quantification. Red bars indicate median values (n=4 mice 
per genotype). n.s.=non-significant (according to Man-Whitney test). 
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Figure 42. Smaller adipocyte size in youn PrimPol-deficient mice. A. Representative BAT sections 
(H&E) from PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice. Scale bar, 50μm B. Adipocyte cell size 
quantification (n=4 animals per genotype).  Red bars indicate the median values. 400 adipocytes were 
measured per mouse. C. Adipocyte cell size quantification. Bar shows the median value (n=4 ). p<0.001 
(according to Mann-Whitney test) 
 
 
Additional experiments are required to ascertain the potential metabolic syndrome in 
PrimPol-deficient mice. At the time of writing this thesis, a pilot experiment with a 
reduced number of aged mice (2 per genotype) revealed that at 75 weeks old PrimPol
-/-
 
females and males exhibited bigger adipocytes in the WAT (Figure 44A and B). 
Furthermore, histopathological analysis revealed the accumulation of fat in the liver 
Figure 43. Lower body temperature in young 
PrimPol deficient mice. Body temperature was 
measured in 9 PrimPol
+/+
 and 10 PrimPol
-/- 
with an 
anal probe. Each point indicates an animal. The lines 
indicate the median. 
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producing steatosis, again reinforcing the notion that the lack of PrimPol causes a 
metabolic syndrome (Figure 44C). 
 
Figure 44. Bigger adipocytes cell size and liver steatosis in old PrimPol
-/-
. A. Representative WAT 
sections, stained with H&E of PrimPol
+/+
 and PrimPol
-/- 
old mice. B. Quantification of adipocyte cell size 
in old mice (72 weeks old) segregated by gender (n>400 adipocyte measured per condition). C. H&E 
liver sections showing the accumulation of fat. 
We conclude from this preliminary analysis that PrimPol seems to be important for fat 
tissue homeostasis. 
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2.6.3. PrimPol deficient mice are tumor prone 
Most of the mice in the longevity studies suffered from standard age-related health 
problems, including spontaneous late-onset tumors. The pathological diagnosis of the 
tumors found and the number of organs infiltrated in each case are shown in Figure 45 
and Supplementary table 1-3 (Annex I). As expected in the C57BL/6J genetic 
background, histiocytic sarcomas and B-cell lymphomas were found at high frequency 
in all genotypes. However, histopathology analyses revealed that PrimPol
-/-
-derived 
hematological tumors had an increased capacity of infiltration and expansion. In some 
cases tumoral cells were found in as many as 18 organs, including some of the typical 
target organs from metastatic lymphomas like liver, lung and intestine, but also, other 
tissues in which metastasis are hallmarks of an aggressive pattern such as skin, heart 
and muscle (Figure 45D). 
Apart from hematological tumors, PrimPol
-/-
 mice presented a higher incidence of 
hepatocarcinomas, which seem to be gender-specific (40% of males; no cases in 
females). Notably, hepatocarcinomas are linked to metabolic syndrome and obesity so 
we hypothesized that the appearance of this tumor type was a direct consequence of the 
obesity in PrimPol
-/-
 mice. Albeit with lower frequency, PrimPol
-/-
 mice also developed 
lung adenoma, fibrosarcoma and angiosarcoma. Interestingly, 30% of PrimPol
-/-
 mice 
developed more than one tumor and in few cases displayed a phenomenon known as 
“tumor collision”, in which two different hematological tumor types compete in the 
same organ/tissue (Figure 45C).  
In summary, these results show that PrimPol loss enhances spontaneous tumorigenesis 
suggesting again that PrimPol may act as tumor suppressor gene.  
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Figure 45. PrimPol deficiency leads to an increase in tumorigenesis. A. Histogram shows tumor 
incidence in PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/- 
mice as identified in the necropsy. The group of mice 
having more than one tumor displayed different combinations (e.g. lymphoma + hepatocarcinoma, lung 
adenoma + hepatocarcinoma, hemangioma + lymphoma). B. Representative H&E stainings of 
histopathological findings in PrimPol
-/- 
mice. i) B-cell lymphoma; ii) Histiocytic sarcoma; iii) 
Fibrosarcoma; iv) Lung adenoma; v) Hepatocarcinoma. In the latter, a blow-up section shows an area of 
massive lipidosis. C. Aggressive pattern of hematological neoplasia in PrimPol
-/- 
mice. (left panel) 
Characteristic H&E staining of a histiocytic sarcoma and B-cell lymphoma in the liver, a feature known 
as “tumor collision”. (right panel) Metastatic B-cell lymphoma infiltrating the dermis and muscle layer in 
the skin. Red arrows indicate infiltration sites. 
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Chapter 3: PrimPol deficiency leads to UV-susceptibility 
3.1. PrimPol deficient mice are sensitive to acute UV radiation 
Due to the relevance of PrimPol function in the response of cultured cells to UV 
radiation and the observation that PrimPol is highly expressed in the skin, we decided to 
test whether PrimPol-deficient mice would be sensitive to UV-B radiation.  
In the skin of normal mice, UV radiation causes a well-established cascade of responses 
including a burst in proliferation that causes temporary protective thickening and the 
replacement of damaged cells (Lu et al., 1999, Lange et al., 2013). To study the 
sensitivity to acute UV radiation, we irradiated 8-week-old PrimPol
+/+
, PrimPol
+/-
 and 
PrimPol
-/-
 mice with a single dose of 3000 J/m
2
 UV-B and skin sections were examined 
in cohorts of mice untreated and after 1-5 days (Figure 46A). The hyperplasia induced 
by UV normally subsides after 4-5 days. In addition, 30 minutes before euthanasia, 
BrdU was injected intraperitoneally (100μg/mg body weight) to the mice in order to 
monitor DNA replication in epidermal cells. PrimPol
+/+
 and PrimPol
+/-
 skin sections 
displayed the expected increase in epidermal thickness that was stabilized by d3-4 and 
decreased by d5. In contrast, PrimPol
-/-
 mice displayed higher epidermal thickness 
compared to PrimPol
+/+
 and PrimPol
+/-
 at all time points. In days 4 and 5 this difference 
in epidermal thickness becomes statistically significant (Figure 46B and C).  
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Figure 46. Inefficient repair of UV-damaged skin of PrimPol
-/-
 mice. A. Schematic of the experiment. 
4 animals (2 males and 2 females) of PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice per day. BrdU was 
injected 30 min before euthanasia. B. Representative H&E stainings of skin sections of PrimPol
+/+
, 
PrimPol
+/-
 and PrimPol
-/-
 mice prepared at the indicated time points after UV-B irradiation. Scale bar, 100 
μm. C. Quantification of epidermal thickness (meand +/- SEM) in PrimPol+/+, PrimPol+/- and PrimPol-/- 
mice (n=4 mice per time point). PrimPol deficient mice present higher hyperplasia in all the time points. 
*p<0.05 according to Fisher t-test.  
 
Importantly, UV-induced epidermal thickening in PrimPol
-/-
 mice
 
was caused by cell 
swelling and intercellular edema rather than an increase in cell number, as deduced from 
the lower number of epidermal cells per mm of linear skin (Figure 47A and XB).  
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Figure 47. Reduced cellularity in the skin of PrimPol
-/-
 mice after UV-B 
irradiation. A. Skin sections stained with H&E from PrimPol
+/-
 and PrimPol
-/- 
at 72h 
after UV. Red arrow indicates zones with low cellular density. Scale bar, 100 μm B. 
Quantification of total interfollicular epidermal cells per mm of linear skin (mean value 
+/- SEM) from the PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice described in Figure 46. 
PrimPol-deficient mice present less cellularity in all the time points. *p<0.05 according 
to Fisher t-test.  
 
When BrdU incorporation was analyzed by IHC in interfollicular epidermal cells and 
follicular cells, we observed that PrimPol
+/+
 and PrimPol
+/-
 displayed a normal burst in 
DNA replication 48h after UV irradiation and a progressive decrease in later time 
points. In contrast, the same cells in PrimPol
-/-
 mice failed to incorporate the BrdU at the 
same extent, explaining the lower cell density and suggesting a problem in the 
replacement of damaged skin cells (Figure 48A and B). To directly test the 
accumulation of cells with damaged DNA, we evaluated the presence of γH2AX by 
IHC. All mice tested presented a high percentage of positive cells for γH2AX upon 24h 
of UV irradiation, the percentage of γH2AX-positive cells in PrimPol+/+ and PrimPol+/- 
skin decreased rapidly with time being almost undetectable by 96h (Figure 48B). Again, 
in contrast to PrimPol
+/+
 and PrimPol
+/-
 mice, PrimPol
-/-
 skin displayed longer 
A 
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persistence of the γH2AX DNA damage marker consistent with a delay in the 
replacement of damaged cells (Figure 48Cand D). 
 
Figure 48. Limited cell proliferation in the epidermis of PrimPol-deficient mice following UV 
irradiation. A. Representative BrdU-stained skin sections from PrimPol
+/+
and PrimPol
-/-
 mice isolated 48 
h after UV. Red arrows point interfollicular epidermal cells and black arrows point hair follicle cells. 
Scale bar, 100 μm. B. Percentage of BrdU-positive cells (mean value +/- SEM) in the basal layer of the 
epidermis (left) and hair follicle (right) of  PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice at the indicated time 
points. *p<0.05 according to Fisher t-test (n=4 mice per genotype and time point). C. Representative of 
γH2AX-stained skin sections from PrimPol+/+and PrimPol-/- mice isolated 48 h after UV. Scale bar, 100 
μm. D. Percentage of γH2AX-positive cells (mean value +/- SEM) in the basal layer of the epidermis 
(left) and hair follicle (right) of  PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice at the indicated time points. 
*p<0.05, **p<0.01, according to Fisher t-test (n=4 mice per genotype and time point).  
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In addition to the skin, PrimPol loss also had a negative impact in the eye. Three days 
after UV-B irradiation (3,000 J/m
2
 and 3,500 J/m
2), a higher level of γH2AX in the 
cornea was observed by IHC in PrimPol
-/-
 corneas compared to PrimPol
+/+
 littermates 
(Figure 49A and B). 
 
Figure 49. Accumulation of γH2AX in the cornea upon UV-irradiation. A. Representative 
immunohistochemical stainings γH2AX in eye sections from PrimPol+/+and PrimPol-/- mice 72h after a 
single dose (3,000 J/m
2
) of UV-B. Black arrows point the cornea. Scale bar, 100 μm. B. Percentage of 
γH2AX-positive cells (mean value +/- SEM) in the cornea from PrimPol+/+ and PrimPol-/- mice (n=4 mice 
per genotype and condition). *p<0.05 according to Fisher t-test. 
These results indicate that PrimPol plays an important role in the response to acute UV-
B radiation.   
3.2. PrimPol deficient mice are not hypersensitive to TPA 
As discussed above, PrimPol deficiency leads to UV-light sensitivity. Due to the fact 
that PrimPol is also able to bypass non-UV light induced lesions such as 8-oxo-G, we 
tested whether PrimPol deficiency sensitizes the skin to other source of DNA damage, 
such as 12-O-tetradecanoylphorbol-13-acetate (TPA). TPA is a potent tumor promoter 
that induces cell proliferation, skin hyperplasia, moderate inflammation and the 
production of reactive oxygen species (Lange et al., 2013). TPA (four doses of 3.4ng) 
was applied to the back skin of 8-week-old mice (Figure 50A). The degree of 
hyperplasia and cellularity was similar in PrimPol
+/+
 and PrimPol
+/-
. It was slightly 
reduced in PrimPol
-/-
 mice although the differences did not reach stadistical significance 
(Figure 50B and C). In addition, no statistically differences were observed in terms of 
BrdU incorporation and γH2AX levels among the three genotypes (Figure 50C and D).  
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We conclude from this experiment that PrimPol deficiency does not affect the 
sensitivity of skin to TPA in the condition tested, although we cannot rule out that 
higher TPA concentrations might have produced some effects in PrimPol-deficient 
mice. 
  
Figure 50. Normal response to TPA in PrimPol-deficient mice. A. Schematic of the experiment. 
PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice (2 males and 2 females) were treated with 3.4 ng TPA four 
times. BrdU was injected i.p. 30 min before euthanasia. B. Representative of H&E stainings of skin 
sections of PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice either untreated or 48h after the application of TPA 
in the back skin. Scale bar, 100 μm. C. Quantification of epidermal thickness (mean +/- SEM) of 
PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice (n=6). D. Quantification of total interfollicular epidermal cells 
per mm of linear skin (mean +/- SEM) from PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice (n=6). E. 
Percentage of BrdU-positive cells (mean value +/- SEM) in the basal layer of the epiderm of PrimPol
+/+
, 
PrimPol
+/-
 and PrimPol
-/-
 mice (n=4). F. Percentage of γH2AX-positive cells (mean value +/- SEM) in the 
basal layer of the epidermis of  PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice (n=4). n.s.: non-significant. 
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3.3. Chronic exposure to UV-B radiation sensitizes PrimPol
-/-
 mice to tumor 
development 
Other mouse models with deficiencies in genes responsible for NER, BER or TLS 
polymerases also show sensitivity to UV radiation. In most cases, these mice developed 
tumors after chronic UV exposure. As described above, PrimPol plays a protective role 
to an acute high dose of UV radiation, and we decided to test the effect of chronic UV 
in tumorigenesis. Young mice (from 8 to 10 weeks old) were irradiated (1,800 J/m
2 
three times a week) during 40 weeks. Tumor formation was monitored for the duration 
of the experiment and mice were euthanized following the humane end points defined 
by the IUCAC guidelines of ISCIII (“standard”). When this protocol (Figure 51A) was 
applied PrimPol
-/-
 developed more and bigger papillomas than the PrimPol
+/+
 and 
PrimPol
+/-
 mice (Figure 51B and C). Besides, several papillomas in PrimPol
-/-
 mice 
displayed signs of malignity, although full progression towards SCC was not observed. 
This could be related to the fact that C57BL/6J genetic background is highly resistant to 
the malignization process from papilloma to SCC (Figure 51D). 
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Figure 51. PrimPol deficient mice are susceptible to UV-induced carcinogenesis. A. Schematic of the 
experiment. PrimPol
+/+
, PrimPol
+/-
 and PrimPol
-/-
 mice were irradiatiated at a dose of 1,800 J/m
2
 three 
times per week during 40 weeks. After this chronic UV scheme, mice were kept five additional weeks 
without irradiation. B. Representative H&E stainings of papilloma lesions from PrimPol
+/+
 and PrimPol
-/-
 
mice. C. Number of papillomas per mouse (left) and distribution of papilloma size (right) in PrimPol
+/+
, 
PrimPol
+/-
 and PrimPol
-/-
 mice (n= 13 PrimPol
+/+
, 11 PrimPol
+/-
 and 11 PrimPol
-/-
) D. Representative H&E 
stainings of skin papilloma sections from PrimPol
-/-  
mice with a higher degree of malignancy. 
Apart from papillomas (an epithelial tumor type), two PrimPol
-/-
 mice developed 
sarcomas (a mesenchymal tumor type) (Figure 52A). Besides skin tumors, one 
PrimPol
+/-
 and three PrimPol
-/-
 mice developed hemangiomas in the eyes (Figure 52B). 
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Figure 52. Mesenchymal tumor types in PrimPol-deficient mice. A. Representative picture of a 
hemangioma in the eye (black arrow; scale bar, 1 cm) and two H&E sections of eye hemangiomas in 
PrimPol
-/- 
mice following chronic UV irradiation (see Figure 51A). Scale bar, 1 cm. B. Representative 
picture of a large sarcoma lesion (red arrow; scale bar, 1 cm). Right, H&E sections of two different 
sarcomas in PrimPol
-/- 
mice.  
In summary, PrimPol deficiency increased the sensitivity to UV-induced tumorigenesis. 
Most of the tumors were benign papillomas but notably, two other types of tumors 
(sarcomas and hemangiomas) were also detected. 
3.4. Melanoma susceptibility in PrimPol-deficient mice? 
The experiments described in the previous sections only tested the susceptibility at 
PrimPol-deficient mice to epithelial and mesenchymal tumors induced by UV-B-This 
excludes the cutaneous malignant melanomas (CMM), which in mice require a different 
regime of irradiation that combines UV-A and UV-B. In order to study the possible 
implication of PrimPol in preventing CMM development, cohorts of newborn mice 
(3.5d) was irradiated (3,310 J/m
2
 UV-A and 6,240 J/m
2
 UV-B) following a described 
protocol (Noonan et al., 2001). This experiment is currently in progress. At the time of 
writing this thesis (18 weeks after irradiation) no CMMs had been observed. 
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DISCUSSION 
1. Structure-function analysis in human PrimPol 
1.1 Functional importance of the conserved WFYY motif of human PrimPol  
Our initial interest in the conserved motif WFYY was driven by a study of exome 
sequencing that implicated a point mutation (Y89D) in PrimPol in the development of 
high myopia in human patients (Zhou et al., 2013). Tyr89 is located within a conserved 
motif (WFYY) in higher eukaryotes. A detailed amino acid alignment revealed that 
Trp87 and Tyr90 residues, both located in the vicinity of Tyr89, are strictly invariant. In 
the first part of this dissertation, we have described a structure-function analysis that 
shows how the “pathological” mutation Y89D does not affect the activity of PrimPol 
either in vitro or in vivo. Controversially, a recent study claims that Y89D mutation 
affects negatively the DNA binding capacity and biochemical activities of PrimPol 
(Keen et al., 2014). However, the authors in this report indicated that Y89D mutation 
induces structural changes in PrimPol. Therefore, its lower activity in vitro is likely a 
consequence of inefficient protein folding during expression and purification, rather 
than an effect of the mutation Y89D per se. Furthermore, Keen et al. (2014) report that 
the ability of Y89D mutant to reconstitute the loss of endogenous PrimPol was also 
compromised. In contrast, our results show that Y89D is perfectly capable of 
substituting for endogenous PrimPol in an unchallenged S phase and during the 
response to UV irradiation. The different results could be related to the fact that Keen et 
al. (2014) try to reconstitute the loss of endogenous PrimPol in avian DT40 cells with 
human PrimPol. This heterologous system may not be completely suitable to validate 
the activity of PrimPol mutations. More importantly, a subsequent genetic study has 
revealed that the Y89D is a common polymorphic variant that appears in the control 
population with similar frequency than in patients with high myopia (Li et al., 2015). 
This study correctly points out that the conclusions of Keen et al. (2014) and Zhou et al. 
(2013) need to be re-evaluated. 
While the analysis of Y89D mutation turned out to be a “red herring”, it pointed us in 
the direction of the conserved WYFF motif. In vitro experiments conducted in the 
laboratory of Dr. Luis Blanco (CBMSO, Madrid) revealed that mutations in Trp87 
(W87G) and Tyr90 (Y90D) rendered PrimPol protein completely inactive for both 
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primase and polymerase activities. In addition, PrimPol carrying a mutation in Phe88 
(F88L) was still functional but with reduced activity. In this thesis, we tested the 
functionality of these PrimPol mutant versions in different conditions in vivo. Using 
single-molecule analysis of DNA replication in HeLa-shPrimPol cells, we found that 
W87G and Y90D mutants failed to compensate for the loss of endogenous PrimPol in 
all conditions tested. Interestingly, F88L mutant could substitute for the function of 
endogenous PrimPol in an unperturbed S-phase, but not when the forks were stalled by 
UV or HU. The ability to restart forks resides mainly in the primase activity of PrimPol 
(Mourón et al., 2013). These results suggest that the partial primase activity left in the 
F88L mutant is capable of dealing with endogenous fork stalling, but fails to do so 
when DNA replication is extensively challenged with UV irradiation or dNTP attrition. 
Mutations that affect the capacity of TLS polymerases to bind DNA have been 
described, such as mutation in Phe290 in human Polη that is linked to a variant of 
Xeroderma pigmentosum (Biertümpfel et al., 2010). However, all the PrimPol mutants 
described here displayed normal binding to DNA in EMSA assays. Our results are 
consistent with the in vitro data generated in Dr. L. Blanco’s laboratory, which indicate 
that amino acids within the WFYY motif are important for the formation of the 
(E:DNA:dNTP) preternary complex. In other AEP proteins involved in non-
homologous end-joining (NHEJ), an invariant Phe residue plays a crucial role in the 
recognition and orientation of both the template and the incoming bases (preternary 
complex) into the active site (Pitcher et al., 2007; Brisset et al., 2010). In human 
PrimPol, W87G and Y90D mutations completely prevented the formation of this 
complex, and F88L affected it considerably. Even Y89D PrimPol mutant seemed to be 
slightly affected in preternary complex formation. We conclude that Trp87 and Tyr90 
residues in human PrimPol, shown in vitro to participate in preternary complex 
formation, are essential in vivo. 
1.2. Functional importance of Tyr100 in human PrimPol 
Tyr100 is a conserved residue located between the A motif and the hydrophobic pocket 
WFYY in human PrimPol. This predicts that structurally, Tyr100 could be located close 
to the DNA/NTPs entrance channel. Sequence alignment shows that Tyr100 is 
substituted in other AEP primases, including Prim1, for a histidine. The identity of this 
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residue may influence the discrimination between NTPs and dNTPs. While a Tyr 
residue in the entrance seems to favor the incorporation of dNTPs over NTPs, primases 
with a His in this position insert preferentially NTPs. Moreover, the mutation Y100H 
has been found in a human cancer cell line (cBIOPORTAL; Cerami et al., 2012; Gao et 
al., 2013). Therefore, a Y100H human PrimPol variant was generated and analyzed. In 
vitro data provided by Dr. L. Blanco laboratory revealed that the Y100H mutant 
displayed primase and polymerase activity, but this specific Tyr to His change was 
sufficient to alter the balance of dNTPs vs NTPs insertion, favoring the insertion of 
NTPs.  It should be noted that in the absence of NTPs, Y100H is still able to use dNTPs. 
In our work, we tested whether Y100H PrimPol was able to substitute for endogenous 
PrimPol in HeLa cells. Interestingly, the mutant Y100H was active, displaying normal 
rates of fork progression in an unchallenged S phase and efficiently promoting fork 
restart after UV irradiation. These results suggest that this mutation does not prevent the 
normal functions of PrimPol in S phase. However, we still do not know whether these 
functions imply a higher incorporation of NTPs in vivo. Incorporation of 
ribonucleotides in the genome increases genomic instability and can lead to cancer if 
not properly repaired (reviewed in Williams and Kunkel, 2013). Future experiments will 
determine whether Y100H PrimPol protein causes genomic instability, and whether its 
activity can be tolerated only in the presence of efficient DNA repair pathways. 
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2. Role of PrimPol protein in vivo: characterization of a mouse KO 
model 
2.1. PrimPol is not essential for mouse development 
PrimPol-deficient mice are viable and born at Mendelian rates. Therefore, we first 
conclude that the functions of PrimPol are not essential during development. Adult mice 
do not display visible phenotypes until mid-age, when they start to gain weight and 
develop alopecia.  
The obesity in old PrimPol KO mice suggests that the lack of PrimPol causes a 
metabolic syndrome. Several links have been established between enzymes that 
maintain genome instability and the development of metabolic syndrome. The 
accumulation of metabolic ROS is known to produce DNA damage in adipocytes and 
other cell types, mainly 8-oxo-G base modifications that could require the action of 
PrimPol or other enzymes involved in DDT or DNA repair. Furthermore, DDR key 
gene ‘ataxia telangiectasia mutated’ (ATM) mediates an antioxidant action that may be 
relevant to metabolic syndrome (Schneider et al., 2006). Several mouse models in 
which DNA repair enzymes have been ablated are associated with metabolic syndrome 
and abnormal body weight, e.g. mice deficient in BER genes Neil1 or Ogg1 (Vartanian 
et al., 2006; Sampath et al., 2011; Sampath et al., 2012). Interestingly, mice deficient in 
NER genes XP-A or ERCC1-XPF develop lipodystrophy, the contrary phenotype 
(Karakasilioti et al., 2013; Fang et al., 2014). Apart from DNA repair proteins, mice 
defective in DDT genes have also shown obesity: ablation of Polη causes adipose tissue 
senescence that eventually leads to metabolic syndrome (Chen et al., 2015).  
How PrimPol deficiency leads to obesity is still not clear. Given the antecedents with 
other mouse strains, it could be via a mechanism similar to DDT protein Polη. It could 
also be hypothesized that PrimPol participates in BER processes. Finally, since PrimPol 
is also a mitochondrial protein we cannot rule out that mitochondrial alterations cause 
problems with lipid metabolism. Indeed, the alterations in brown adipose tissues (BAT) 
observed in PrimPol-deficient mice could be linked to mitochondrial activity, as the 
mitochondrial complex III ROS regulates adipocyte differentiation in BAT (Tormos et 
al., 2011) and deficient mitochondrial ATP production also produces alterations in BAT 
(Hao et al., 2015). Indirectly, deficiency in the glucose metabolism that is also sustained 
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from mitochondrial activity also alters BAT composition and thermogenesis activity 
(Albert et al., 2016). These possibilities are not mutually exclusive and all could 
contribute to the obese phenotype observed in the absence of PrimPol (Figure 53). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The other obvious phenotype detected in the longevity studies was that PrimPol-
deficient females developed alopecia. This phenotype has neither been described in 
NER- or BER-defective mice, nor in mice defective in other TLS polymerases such as 
Figure 53. Hypothetical mechanisms that could link PrimPol to obesity. PrimPol facilitates nuclear 
and mitochondrial DNA replication by priming ahead of damaged sites. In its absence, inefficient 
replication causes an accumulation of lesions in the DNA that may lead to adipose tissue senescence and 
eventual obesity as reported in other mouse models with deficient DDT. In addition, the accumulation of 
mutations in mtDNA may impair the TCA cycle, increasing the production of ROS. In the absence of 
PrimPol there is a compensatory hiperproliferation in mitochondria that can further exacerbate oxidative 
damage and contribute to the hypertophy of adipose tissue.  
PrimPol 
Hard-to-replicate sites 
G4 quadruplexes? 
Common fragile sites? 
Endogenous ROS production  
Accumulation of DNA 
lesions 
Accumulation of mtDNA lesions 
Impairment of TCA 
cycle Higher ROS production 
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Polη or Polθ. Because mitochondrial ROS is known to promote epidermal 
differentiation and hair follicle development (Hamanaka et al., 2013) it is likely that the 
alopecic phenotype in PrimPol is caused by defects in mitochondria. Besides PrimPol, 
Polζ is the only TLS polymerase described in mitochondria so far (García-Gómez et al., 
2013; Singh et al., 2015). Interestingly, mice deficient in Polζ do not have hair because 
of an atrophy in the hair follicle (Lange et al., 2013). Histopathology analysis of the 
skin sections of PrimPol-deficient mice revealed skin sections revealed the presence of 
“folded follicles”, aberrant structures in which excessive keratinization prevents the 
release of hair from the follicle. This analysis also revealed the atrophy of sebaceous 
glands accompanied by a recruitment of mast cells. 
In summary, PrimPol function seems important for the maintenance of hair growth in 
adult mice, possibly by maintaining proper mitochondrial activity around the hair 
follicles. More experiments will be required to characterize this phenotype and to 
understand why it is exclusive of female mice.  
2.2. PrimPol: a tumor suppressor gene? 
Our study revealed that the lifespan of PrimPol-deficient mice is slightly reduced, 
mainly due to the appearance of age-related tumors at an earlier stage. In fact, PrimPol 
KO mice developed more and different tumors than wt littermates. Aged C57BL/6 mice 
frequently develop hematological tumors, but their incidence was higher in PrimPol-
deficient mice. Besides, the histopathological finding of lymphoma cells in more organs 
of PrimPol KO mice suggests an aggressive pattern. On the same token, rare tumor 
types have been detected in PrimPol KO mice, including hepatocellular carcinomas 
(HCC), hemangiomas, angiosarcomas and pulmonar adenomas. HCC and pulmonary 
adenomas have been linked to obesity. Moreover, hepatocarcinomas only appeared in 
males, as we observed. The mechanisms underlying the development of HCC remain 
poorly understood, but it is worth noting that mice defective in BER, e.g. Nth1- and 
Neil1-deficient strains, are also prone to HCC and pulmonary adenocarcinomas (Chan 
et al., 2009). 
At the cellular level, we have observed a higher efficiency of Ras-mediated 
transformation capacity in PrimPol-deficient MEFs. Combined with the in vivo 
tumorigenesis data, we strongly favor the idea that PrimPol is a tumor suppressor gene. 
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In agreement with this hypothesis, a cBioPortal analysis indicates that PrimPol is 
mainly mutated or homozigously deleted (Figure 54). It is worth noting that PrimPol 
gene is located next to the Caspase-3 gene, so PrimPol loss may be produced in some 
cases also as a consequence of the loss of heterozygozity (LOH) of this gene during 
cancer formation.  
 
 
 
 
 
 
 
 
 
 
In contrast, TLS polymerases are frequently overexpressed in tumors and are a poor-
prognosis marker in chemotherapies based on cisplatin (Ceppi et al., 2009; Wang et al., 
2010). Considering that PrimPol acts preferentially as a primase rather than a TLS 
polymerase during DDT, it is not surprising that it is not amplified or overexpressed in 
tumors like the TLS polymerases.  
Whether DNA polymerases, particularly TLS polymerases, can prevent or contribute to 
cancer development is a complex issue. As summarized in the next few paragraphs, 
several DNA polymerase KO models are tumor-prone (Table 5). 
Germline mutations in the proofreading domain of replicative Pold1 and Pole 
predispose to colorectal adenomas and carcinomas in humans (Palles et al., 2013). This 
result underscores the notion that many point mutations in cancer cells stem from DNA 
polymerase errors that are not repaired. In addition, transgenic mice with an 
Figure 54. PrimPol alterations in human tumor samples. PrimPol is most frequently homozigously 
deleted (blue) or mutated (green). Many of the mutations are presumably inactivating. The type of 
cancer with the highest frequency of homozygous deletion of PrimPol is diffuse large B-cell lymphoma. 
In constrast to other tumors, all PrimPol alterations found in prostate cancer are amplifications.  
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exonuclease-deficient (exo) Pold1 developed thymic lymphomas, skin tumors, lung 
adenocarcinomas or teratomas within the first eight months of life. Pole
exo/exo
 mice died 
prematurely of intestinal adenomas and adenocarcinomas. The combination of 
Pold1
exo/exo
 and Pole
exo/exo
 mice died even faster, mainly from thymic lymphomas 
(Goldsby et al., 2002; Uchimura et al., 2009; Albertson et al., 2009).  
 
DNA 
polymerase 
Gene  Phenotype of knockout mice 
Polα Pola1 Embryonic lethality 
Polε Pole Embryonic lethality. Tumorigenesis in Poleexo/exo 
Polδ Pold1 
Embryonic lethality after E4.5. Tumorigenesis in Pold1
exo/exo
 and Pold1
exo/-
 
mice 
Polζ Rev3l 
Embryonic lethality after E9.5. p53 deficiency cannot rescue the lethality. 
Spontaneous tumor development in condicional knock-out mice 
(constitutive or tissue-specific) 
Polγ Polg Embryonic lethality after E7.5 
Polθ Polq 
Viable and fertile. High micronuclei frequency in reticulocytes. Very low 
viability of Polq
-/-
; Atm
-/-
 mice 
Polν Poln Unknown 
Polη Polh 
Viable and fertile. Susceptible to UV radiation. Generation of A:T mutations 
during SHM. Obesity. 
Polι Poli Viable and fertile. UV susceptibility 
Polκ Polk Viable and fertile. Reduced life span. Increased mutations in tissues. 
REV1 Rev1 
Inviable on the C57BL/6 background, but viable on the 129/OLA 
background. Loss of C:G transversions during SHM. 
Polβ Polb 
Exhibit apoptsosis in post-mitotic neuronal cells and die at birth. Loss of p53 
rescues the phenotype. Polb
+/-
 mice develop spontaneous lymphomas. 
Polλ Poll Viable, fertile and display reduced Ig heavy chain junction viability 
Polμ Polm Viable, fertile and display reduced Ig light chain junction viability 
TDT Dntt Viable, fertile and display reduced Ig heavy chain junction viability 
Table 5. DNA polymerase knockout mouse phenotypes. This table shows the phenotypes observed in 
knockout mice for the catalytic subunit of the indicated DNA polymerase. Atm, ataxia-telangiectasia 
mutated; E, embryonic day; exo: exonuclease-deficient; Pol, polymerase; TDT, terminal transferase; UV: 
Ultraviolet. 
 
Interestingly, the Polα/Prim1 complex is amplified in many tumor types, except for a 
few cases (head and neck SCC, esophageal carcinoma and lung SCC, among others) in 
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which Pola1 appears to be deleted. Prim1 is also homozygously deleted in 42% of 
adenoid cystic breast carcinoma and 15% of adenoid carcinomas. These observations 
suggest that another enzyme, possibly PrimPol, could substitute for Polα/Prim1 function 
in the tumors. It is unlikely, however, that PrimPol can substitute for Polα/Prim1 in 
normal cells and tissues, because Polα-/- mice show an embryonic lethality phenotype.  
A Pol ζ-/- (Rev3L-/-) mouse model displays embryonic lethality at E9.5, suggesting that 
this TLS polymerase is essential in late embryonic development (Bemark et al., 2000; 
Esposito et al., 2000; Wittschieben et al., 2000). A Pol ζ conditional KO developed 
mammary tumors; ablation of Pol ζ specifically in the skin developed Squamous Cell 
Carcinoma (SCC) in the absence of exogenous DNA damaging factors. To date, Polζ 
KO is the only TLS polymerase-deficient strain that shows an increase in spontaneous 
tumorigenesis (Wittschieben et al., 2010; Lange et al., 2013).  
Heterozygous Polβ+/- mice develop normally but show an increased incidence of 
lymphomas with high infiltration capacity, similar to the tumor aggressiveness observed 
in PrimPol-deficient mice (Cabelof et al., 2006). This intriguing parallelism would also 
be consistent with a possible role of PrimPol in BER, as Polβ. Indeed, a mass-
spectrometry analysis of PrimPol interacting factors in UV-irradiated HeLa chromatin 
extracts showed that PrimPol interacts with BER proteins (Karolina Jodkowska and 
Silvana Mourón, unpublished data). Of note, PrimPol is highly expressed in lymphatic 
tissues, where BER occurs during SHM. One possibility is that PrimPol acts as a 
primase during DDT after exogenous DNA damage such as UV, but also plays a role in 
endogenous SHM. Indeed, it is been recently proposed that PrimPol serves as an anti-
mutagenic factor in SHM. When AP sites are endogenously created, PrimPol primes 
ahead of these lesions leaving an unreplicated gap that is resolved preferentially by HR 
without introducing mutations. In the absence of PrimPol, AP sites are repaired by TLS, 
increasing the mutagenesis rate (Pilzecker et al., 2016). PrimPol is needed to facilitate 
replication through special DNA structures such as G4 quadruplexes (Bailey et al., 
2016). In this sense, the aggressive pattern of the tumors in PrimPol
-/-
 mice could be a 
consequence of the accumulation of mutations if TLS is preferred over HR during 
endogenous DNA repair processes.    
Finally, the mitochondrial replicative polymerase Polγ is amplified in a large number of 
tumors (Cerami et al., 2012; Gao et al., 2013). As expected, KO mice are lethal during 
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embryogenesis (E7.5; Hance et al., 2005). Polγ point mutations have been linked to 
other diseases and syndromes such as Progressive External Ophtalmoplegia (PEO), 
Alper’s syndrome, ataxia-neuropathy, dysarthria, premature menopause and infertility 
(reviewed in Loed and Monnat, 2008).  
2.3. PrimPol protects the skin from UV-induced DNA damage 
Several antecedents suggested that PrimPol would play an important role in the cellular 
response to UV irradiation in vivo. First, cellular experiments showed that PrimPol 
association to chromatin was increased after UV, particularly to the damaged DNA 
sites. Single molecule analyses of DNA replication revealed that the primase activity of 
PrimPol was strictly required to mediate fork restart after UV-induced DNA damage 
(Mourón et al., 2013). 
We have found that MEFs deficient in PrimPol undergo difficulties to complete DNA 
replication after an UV challenge, which are eventually solved by other mechanisms. 
Avian DT40 cells lacking PrimPol accumulate in G2/M after UV irradiation and this 
block is resolved later on by other mechanisms (Bailey et al., 2012). S-phase 
progression is also perturbed in Polη-, Polι-, Polκ- and Rev1-deficient MEFs after UV 
(Temviriyanukul et al., 2012; Jansen et al., 2014). Therefore, the lack of PrimPol, as 
that of TLS polymerases, makes the cells more susceptible to UV light. 
Furthermore, PrimPol deficiency leads to an accumulation of CPD and (6,4)-pp lesions 
upon UV, a phenotype that had been also reported in Nrf2- or XPC-deficient skin cells 
(Tsaalbi-Shtylik et al., 2009; Schäfer et al., 2010). Therefore, PrimPol participates in 
the response to UV that facilitates the elimination of photoproducts in the DNA of 
damaged cells. 
In this thesis we have characterized the UV susceptibility of PrimPol-deficient mice, 
using several approaches. First, we compared the skin response of PrimPol+/+, 
PrimPol
+/-
 and PrimPol
-/-
 mice to acute UV irradiation. In normal mice, a UV dosage of 
3000J/m
2
 induces DNA damage in the external layers of the epidermis that can be 
readily monitored by γH2AX. This is followed by a proliferative response in the basal 
layer to replace the damaged cells, causing a tissue hyperplasia that normally lasts 3-4 
days. Cell proliferation in this stage can also be monitored by BrdU incorporation. 
Interestingly, PrimPol-deficient mice displayed a delayed, inefficient reaction to UV. 
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The proliferation response was incomplete (as seen by the lower percentage of BrdU-
positive cells) and the epidermal thickening was caused by inflammation rather than by 
an increase in cellularity. As a consequence, the DNA damage was persistent for a 
longer time.  
Strong susceptibility to UV has also been observed in mice deficient for XPA, XPC or 
Polζ. Polζ mice display a strong phenotype, as acute UV treatment causes skin 
ulceration after 10 days (Nakane et al., 1995; Tsaalbi-Shtylik et al., 2009; Lange et al., 
2013). In PrimPol-deficient mice, healing starts by five days post-UV, suggesting the 
participation of compensatory mechanisms. 
We also studied how mice responded to a regime of chronic UV exposure, which is 
known to induce benign papillomas in wt mice. After 40 weeks of repeated UV 
exposure, the frequency of papilloma formation in PrimPol-deficient mice was 
significantly higher than in wt littermates. No progression towards squamous cell 
carcinomas (SCC) was observed, but it should be noted that the C57BL/6J background 
is particularly resistant to transformation from papillomas to SCC (Woodworth et al., 
2004). Albeit with lower frequency, mesenchymal tumors such as sarcomas and 
hemangiomas, were detected in PrimPol KO mice upon continued UV exposure. 
Therefore, PrimPol contributes to prevent cell transformation induced by UV-promoted 
DNA damage.  
UV-induced skin tumors are common in mice deficient in DDT and DNA repair 
pathways. Polη or Polι KO strains (both TLS polymerases capable of bypassing CPD 
lesions) developed SCC and skin mesenchymal tumors, respectively (Lin et al., 2006; 
Ohkumo et al., 2006). Notably, Polι is also implicated in BER, so the tumor propensity 
could be caused by deficient lesion bypass or by defective BER pathway.  
As shown in table 6, all mice strains deficient in the NER pathway (XPA, XPC or 
Ercc1) developed SCCs upon UV exposure (Berg et al., 1997; Nakane et al., 1995; de 
Vries et al., 1998; van der Host et al., 2002; Berg et al., 2000; Tsaalbi-Shtylik et al., 
2009; Doig et al., 2006; Cheo et al., 1996; Sands et al., 1995). Similarly, mice defective 
in genes responsible for Cockaine syndrome group A or B (Ercc8 and Ercc6, 
respectively) developed skin carcinomas by 40 weeks (Berg et al., 2000; van der Host et 
al., 2002). Furthermore, mice deficient in BER genes such as Ogg1 developed SCC and 
also mesenchymal tumors (Kunisada et al., 2005).  
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The combined deficiency of DDT and DNA repair pathways leads to stronger 
phenotypes. For instance, the ablation of DDT polymerase REV1 expression in mice 
deficient in NER factor XPC accelerates SCC formation after chronic exposure to UV 
(Tsaalbi-Shtylik et al., 2009). 
Of note, other mice with high levels of RS such as telomeric TRF2-overexpressing mice 
are also more sensitive to UV-induced tumor formation and progression (Muñoz et al., 
2005; Stout et al., 2009). 
Function Gene Genetic Background UVB dose (J/m2) Skin tumors 
NER 
Ercc1 Albino hairless (hr) 125 three times per week SCC 
Xpa Albino hairless (HRA/SKH) -129 32 daily // 80 daily SCC 
Xpa Albino hairless (HRA/SKH) -129 80 daily // 32 daily SCC 
Xpa 129-C57Bl6 mix 2000 three times per week SCC 
Xpa 129-C57Bl6 mix 1200 five times per week SCC 
Xpc 129-C57Bl6 mix 
1200 five times per week 
600 five times per week 
SCC 
Xpc (HRA/SKH) -129-129-C57Bl6 mix 80 daily SCC 
Xpc (HRA/SKH) -129 40 daily SCC 
Xpc 129-C57Bl6 mix 2500 daily SCC 
Xpc 129-C57Bl6 mix 1200 daily SCC 
Ercc6 
(Csb) 
Albino hairless (HRA/SKH) -129- 
C57Bl6 mix 
80 daily SCC 
Ercc8 
(Csa) 
129 C57Bl6 mix 1200 or 600 five times per week SCC 
TLS 
Polh C57Bl6 2000 daily SCC 
Polh  C57Bl6 mix-129 mix 3750 three times per week SCC 
Rev3L C57BL/6 129 mixed or FVB 50 three times per week None (ulceration) 
TLS/BER Poli C57Bl6 2000 daily 
Sarcoma and 
hemangioma. 
TLS/NER 
Xpc and 
Rev1 
(HRA/SKH) -129 mixed 40 daily SCC 
BER Ogg1 C57BL/6 2500 three times per week 
SCC, sarcomas and 
hemangiomas 
TLS-
primase 
PrimPol C57BL/6 1800 three times per week 
Papillomas, 
sarcomas and 
hemangiomas. 
Table 6. UV-B radiation-induced carcinogenesis in DNA repair- or TLS- or a combination of both 
defective mouse models. SCC: Squamous cell carcinoma. 
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Altogether, we conclude that PrimPol is an important factor in the physiological 
response to UV-induced DNA damage. In our model (Figure 55), PrimPol promotes 
DDT by catalyzing the priming event downstream of a lesion. Efficient DDT in S-phase 
would favor later repair of the lesion by error-free HR-mediated mechanisms. In the 
absence of PrimPol, these lesions may be preferentially bypassed by TLS polymerases, 
which entail a higher risk of mutation, chromosomal instability and tumorigenesis. In 
the future, a knock-in mouse strain that encodes a mutant PrimPol version lacking the 
Zn finger domain (i.e. null for primase activity but with intact polymerase activity; 
Mourón et al., 2013) could provide additional genetic evidence that the UV-induced 
tumorigenesis in PrimPol-deficient mice is mainly derived from the lack of primase 
activity.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Other interesting directions for future research could be to monitor the UV 
susceptibility of mice in which the loss of PrimPol is combined with a deficiency in 
Ogg1, Polη, or p53. It would also be interesting to learn whether the inefficient response 
AP sites (SHM) 
G4 quadruplex  
CPDs and (6,4)-pp 
dNTP attrition 
Endogenous oxidative lesions 
Error-free 
“Antimutagenic pathway” 
Error-prone 
“Mutagenic pathway” 
Accumulation of mutations 
Cancer 
Figure 55. General antimutagenic role of PrimPol protein: a model. PrimPol is known to prime new 
DNA synthesis  downstream of the indicated lesions. The unreplicated gap left behind is then repaired by 
homologous recombination, mainly an error free pathway. In the absence of PrimPol, DNA lesions 
would be mainly processed by TLS polymerases which are normally mutagenic.  
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to UV in PrimPol KO mice could be alleviated or reverted in a mouse overexpressing 
photolyase, an enzyme with the ability to break UV photoproducts.   
In summary, in this dissertation we have reported that PrimPol protein, involved in 
DDT, is necessary for the protection against UV damage, and its absence also leads to 
defects in fat tissue homeostasis and hair follicle growth. The higher frequency of 
tumorigenesis in PrimPol KO mice also indicates a tumor suppression function. Future 
studies will increase our knowledge about the possible participation of PrimPol in other 
processes, and the precise contributions of its mitochondrial and nuclear functions.  
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CONCLUSIONS 
1. The point mutation in human PrimPol supposedly implicated in the development of 
high myopia (Y89D) yields a completely functional protein, in vitro and in vivo. 
2. Trp87 and Tyr90 amino acids in the conserved WFYY motif are essential to preserve 
the functionality of PrimPol as a primase and a polymerase. In vitro studies carried out 
by our collaborators indicate that these amino acids are necessary for the formation of 
the enzyme-DNA-NTP preternary complex. 
3. The mutation Y100H in hPrimPol, identified in cancer genomic studies, does not 
affect the functionality of PrimPol in vivo.  
4. PrimPol-deficient MEFs show mild proliferation defects and UV-susceptibility. 
5. PrimPol is not essential for mouse development or fertility. 
6. The absence of PrimPol affects the regulation of adipose tissue and the hair follicle 
structure, by mechanisms that are not yet understood. 
7. PrimPol plays a protective role against UV-induced DNA damage in vivo: PrimPol-
deficient mice are more susceptible to short-term and long-term exposure to UV. 
8. PrimPol-deficient mice present an increased incidence of late-onset tumors, which 
behave more aggressively, affecting the life expectancy by several weeks. 
9. PrimPol acts like a tumor supressor protein in vivo. 
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CONCLUSIONES 
1. La mutación puntual Y89D en la proteína PrimPol humana, supuestamente asociada 
al desarrollo de miopía magna, presenta una funcionalidad normal in vitro e in vivo. 
2. Los aminoácidos Trp87 y Tyr90 del motivo WFYY son esenciales para las 
actividades bioquímicas primasa y polimerasa de PrimPol, así como para preservar su 
funcionalidad in vivo. Estudios llevados a cabo por nuestros colaboradores indican que 
estos dos aminoácidos participan en la formación del complejo preternario enzima-
DNA-NTP. 
3. La mutación Y100H en PrimPol, identificada en estudios genómicos de cáncer, no 
afecta a la funcionalidad de PrimPol in vivo. 
4. MEFs deficientes en PrimPol muestran defectos sutiles en proliferación y una mayor 
susceptibilidad a la radiación UV. 
5. PrimPol no es esencial para el desarrollo del ratón ni para su fertilidad. 
6. La ausencia de PrimPol afecta la regulación del tejido adiposo y la estructura del 
folículo piloso, a través de mecanismos aún no conocidos. 
7. PrimPol tiene un papel protector ante daños en el DNA inducidos por UV in vivo: los 
ratones deficientes en PrimPol son más susceptibles a la irradiación por UV. 
8. Los ratones deficientes en PrimPol presentan una mayor frecuencia de tumores 
asociados al envejecimiento, que además presentan un comportamiento más agresivo y 
reducen la esperanza de vida en varias semanas. 
9. PrimPol actua como un supresor de tumores in vivo. 
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ANNEX I 
Tables containing all the tumors found in the longevity studies according to the 
histopathology analysis are shown below. 
 
PrimPol 
+/+ Case 
Age 
(weeks) Tumor Location Staining IHC 
Males  FCB00136 83 B-cell Lymphoma 
Mesenteric 
glangyons H&E   
  FCB00086 121 
Histiocytic 
sarcoma Spleen H&E   
        Liver H&E   
        Bone Marrow H&E   
        Pleura H&E   
        Thymus H&E   
        Kidney H&E   
  FCB00066 146 Lymphoma Intestine H&E   
  
 
  
 
Mesenteric 
glangyons H&E   
  
 
  
 
Pancreas H&E   
  
 
  
 
Spleen H&E   
        
Salivary gland 
nodes H&E   
  FCB00135 141 Lymphoma 
Mesenteric 
glangyons H&E   
  
 
    Spleen H&E   
        
Peyer's 
Patches H&E   
  FCB00129 98 Lymphoma Spleen H&E   
  
 
  
 
Salivary gland 
nodes H&E   
      
 
Salivary gland  H&E   
Females  FCB00063 78 B-cell Lymphoma Spleen H&E   
    
 
  Liver H&E,  PAX5,CD3 
    
 
  
Adipose 
tissue H&E   
        
Lymphatic 
node H&E   
  FCB00130 83 Lymphoma Spleen H&E PAX5/CD3 
    
 
  Liver H&E   
    
 
  
Lymphatic 
ganglyons H&E   
    
 
  
Adipose 
tissue H&E   
    
 
  Uterus H&E   
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        Lung H&E   
  FCB00037 120 
Hystiocitic 
sarcoma Spleen H&E   
      
 
Intestine H&E   
      
 
Bone Marrow H&E   
        
Salivary 
glands H&E   
  FCB00065 108 Lymphoma Spleen H&E   
        Intestine H&E   
        
Mesenteryc 
nodes H&E   
  FCB00062 97 Lymphoma Spleen H&E   
  FCB00042 101 
Histiocytic 
sarcoma Liver H&E F4/F80 
        
Salivary 
glands H&E F4/F80 
  FCB00132 116 Lymphoma Spleen H&E   
        Liver H&E   
        
Mesenteryc 
nodes H&E   
        
Nerve 
ganglion H&E   
        Lung H&E   
        Intestine H&E   
Supplementary Table 1. Tumors found in PrimPol
+/+
 mice in longevity studies. 
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PrimPol 
+/- 
Case 
Age 
(weeks) 
Tumor Location Staining IHC 
Males FCB28 93 Hyperplasia 
Red pulp 
Spleen 
H&E 
 
   
Histiocytic 
sarcoma 
Lung H&E F4/F80 
    
Liver H&E F4/F81 
 
FCB81 71 Adenoma 
Accesory 
ocular gland 
H&E 
 
   
B-cell Lymphoma Spleen H&E Pax5/CD3 
    
Lymphatic 
ganglyons 
H&E 
 
    
Kidney H&E 
 
    
Bone Marrow H&E 
 
    
Lung H&E 
 
    
Intestine H&E 
 
    
Testis H&E 
 
 
FCB212 56 
Hystiocitic 
sarcoma 
Salivary 
glands 
H&E F4/F80 
    
Spleen H&E 
 
    
Bone Marrow H&E 
 
 
FCB35 96 
Hystiocitic 
sarcoma 
Liver H&E 
 
    
Testis H&E 
 
    
Epididium H&E 
 
 
FCB51 113 Adenoma Lung H&E 
 
 
FCB72 121 
Histiocytic 
sarcoma 
Liver H&E F4/F80 
   
Lymphoma 
Salivary 
glands 
H&E Pax5/CD3 
 
FCB26 120 Lymphoma Spleen H&E 
 
 
FCB44 120 Adenoma Intestine H&E 
 
   
Histiocytic 
sarcoma 
Spleen H&E 
 
 
FCB71 117 
Histiocytic 
sarcoma 
Spleen H&E 
 
    
Liver H&E 
 
   
Adenoma  X2 Lung H&E 
 
 
FCB213 132 Hepatocarcinoma Liver H&E aFP 
     
H&E 
 
     
H&E 
 
     
H&E 
 
Females FCB00061 78 Lymphoma Spleen H&E Pax5/CD3 
    
Bone Marrow H&E 
 
    
Salivary 
glands 
H&E 
 
    
Lymphatic 
ganglyons 
H&E 
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Adipose 
tissue 
H&E 
 
 
FCB79 110 Lymphoma Spleen H&E 
 
    
Kidney H&E 
 
 
FCB68 100 
Follicular 
lymphoma 
Spleen H&E 
 
 
FCB38 93 
Histiocytic 
sarcoma 
Spleen H&E 
 
    
Mesenteryc 
node 
H&E 
 
    
Kidney H&E 
 
    
Liver H&E 
 
    
Intestine H&E 
 
    
Uterus H&E 
 
    
Lung H&E 
 
    
Salivary 
glands nodes 
H&E 
 
    
Pancreas H&E 
 
 
FCB70 126 Lymphoma 
Mesenteryc 
node 
H&E 
 
    
Adipose 
tissue 
H&E 
 
    
Bladder H&E 
 
    
Lung H&E 
 
    
Kidney H&E 
 
    
Liver H&E 
 
    
Spleen H&E 
 
    
Serous 
stomach 
H&E 
 
 
FCB130 83 
Follicular 
lymphoma 
Liver H&E 
 
    
Kidney H&E 
 
    
Spleen H&E 
 
    
Bone Marrow H&E 
 
    
Lung H&E 
 
    
Stomach H&E 
 
    
thyroid gland H&E 
 
    
Salivary gland H&E 
 
    
Salivary gland 
nodes 
H&E 
 
    
Traquea H&E 
 
    
Adipose 
tissue 
H&E 
 
    
Mesenteryc 
node 
H&E 
 
Supplementary Table 2. Tumors found in PrimPol
+/-
 mice in longevity studies. 
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PrimPol 
-/- 
Case 
Age 
(weeks) 
Tumor Location Staining IHC 
Males  FCB00027 86 B-cell lymphoma Spleen H&E CD3/PAX5/F4/80 
    
Liver H&E CD3/PAX5/F4/81 
    
Kidney H&E 
 
   
Chronic 
pancreatitis 
Pancreas H&E 
 
   
Enteritis Intestine H&E 
 
 
FCB00088 58 B-cell lymphoma 
Lymphatic 
ganglyons 
H&E CD3, PAX5 
    
Spleen H&E CD3, PAX5 
    
Bone Marrow H&E 
 
    
Thymus H&E 
 
    
Liver H&E 
 
    
Lung H&E 
 
    
Intestine H&E 
 
    
Testis H&E 
 
    
Pancreas H&E 
 
 
FCB00034 101 Adenoma Lung H&E 
 
 
FCB93 111 Hepatocarcinoma Liver H&E 
 
 
FCB231 94 Angiosarcoma 
Salivary 
glands 
H&E CD31 
 
FCB73 131 Adenoma Lung H&E 
 
 
FCB75 135 Hepatocarcinoma Liver H&E F4/80 
   
Hystiocitic 
sarcoma 
Spleen H&E 
 
 
FCB00089 75 Hepatocarcinoma Liver H&E aFP 
 
FCB90 128 
Histiocytic 
sarcoma 
Spleen H&E 
 
   
Hemangiosarcoma Intesinte H&E 
 
 
FCB84 129 Hepatocarcinoma Liver H&E aFP 
   
Adenoma Lung H&E 
 
Females  FCB00080 87 Fibrosarcoma Muscle H&E 
 
    
Mammary 
glands 
H&E 
 
    
Adipose 
tissue 
H&E 
 
   
Lymphoma Spleen H&E CD3/PAX5 
    
Bone Marrow H&E CD3/PAX5 
  
 
 
Plasmacytoma ?? Spleen H&E 
 
 
 
FCB00094 
 
71 
 
B-cell lymphoma 
Spleen H&E CD3/PAX5 
    
Liver H&E 
 
    
Lymphatic 
ganglyons 
H&E 
 
    
Salivary H&E 
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glands 
    
Bone Marrow H&E 
 
    
Intestine H&E 
 
    
Lung H&E 
 
    
Stomach H&E 
 
    
Uterus H&E 
 
    
Muscle H&E 
 
 
FCB000241 89 B-cell lymphoma 
Lymphatic 
nodes 
H&E 
 
    
Liver H&E 
 
 
FCB00114 108 Lymphoma Spleen H&E 
 
    
Kidney H&E 
 
    
Liver H&E 
 
    
Lymphatic 
nodes 
H&E 
 
    
Lung H&E 
 
    
Thymus H&E 
 
    
Bone Marrow H&E 
 
    
Salivary 
glands 
H&E 
 
    
Thyroid H&E 
 
    
Traquea H&E 
 
    
Serous 
Stomach 
H&E 
 
    
Intesinte H&E 
 
   
Histiocytic 
sarcoma 
Spleen H&E 
 
    
Bone Marrow H&E 
 
    
Liver H&E 
 
 
FCB00050 85 Lymphoma Spleen H&E 
 
    
Liver H&E 
 
 
FCB00125 107 B-cell lymphoma Spleen H&E 
 
    
Liver H&E 
 
    
Lymphatic 
nodes 
H&E 
 
    
Heart 
(auricula) 
H&E 
 
    
Traquea H&E 
 
    
Lung H&E 
 
    
Salivary 
glands 
H&E 
 
    
Thyroid H&E 
 
    
Kidney H&E 
 
    
Ovary H&E 
 
    
Adipose 
tissue 
H&E 
 
    
Bone Marrow H&E 
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Intestine H&E 
 
    
Stomach 
(Serous) 
H&E 
 
 
FCB53 89 Lymphoma Spleen H&E 
 
    
Kidney H&E 
 
    
Pancreas H&E 
 
    
Lung H&E 
 
    
Heart 
(ventricle) 
H&E 
 
    
Thymus H&E 
 
    
Salivary 
glands 
H&E 
 
    
Bone Marrow H&E 
 
    
Muscle H&E 
 
    
Intestine H&E 
 
    
Adipose 
tissue 
H&E 
 
    
Mesenteric 
nodes 
H&E 
 
    
Uterus H&E 
 
    
Liver H&E 
 
    
Serous 
Stomach 
H&E 
 
    
Skin H&E 
 
 
FCB226 94 Papillomas Stomach H&E 
 
   
Lymphoma Intesinte H&E 
 
    
Mesenteric 
nodes 
H&E 
 
    
Adipose 
tissue 
H&E 
 
    
Kidney H&E 
 
    
Salivary 
glands 
H&E 
 
 
FCB129 128 Papilloma Ovary H&E 
 
   
Lymphoma Spleen H&E 
 
Supplementary Table 3. Tumors found in PrimPol
-/-
 mice in longevity studies. 
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